Variant 10 of 11
Variant1:NM_000203.3: c.568_581del p.(Asn190Hisfs*204)
Variant1CAID:CA2801994
Variant 10 of 11
Variant1:NM_000203.3: c.568_581del p.(Asn190Hisfs*204)
Variant1CAID:CA2801994
Variant 9 of 11
Variant1:NM_000203.3: c.494-1G>C
Variant1CAID:CA275298
An integrated multiomic approach as an excellent tool for the diagnosis of metabolic diseases: our first 3720 patients
PMID:35614200
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
A list of 11 IDUA variants identified in cases with MPS is included in Supplemental Table 6, but the variants are not linked to specific patients and are listed individually (not as genotypes). A page note has been added for each variant.
Variant 8 of 11
Variant1:NM_000203.3: c.395T>C p.(Leu132Pro)
Variant1CAID:CA355961295
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: N348K
Variant1ClinVarID:
Variant1CAID: CA355963142
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: L238Q
Variant1ClinVarID: 265418
Variant1CAID: CA2802065
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: V279A
Variant1ClinVarID:
Variant1CAID: CA355962380
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: T103P
Variant1ClinVarID:
Variant1CAID: CA355960996
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: G409R
Variant1ClinVarID: 1084956
Variant1CAID: CA91169920
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case#: Variant not associated with a proband. Variant listed in supplementary materials in Supplementary Table 4
DiseaseAssertion: Mucopolysaccharidosis type I, MPS I
FamilyInfo: N/A
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: S633L
Variant1ClinVarID: 556406
Variant1CAID: CA355966010
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
294
Case#: Patient 29 (see Table 2), 40 weeks, 5 days (Gestational age)
DiseaseAssertion: MPS1-S
FamilyInfo: Sibling of Patient 28 (see Table 2)
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: 1.61 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.474-2A>G (new nomenclature: c.386-2A>G)
Variant1ClinVarID: 222994
Variant1CAID: CA356991
Variant2: c.1148G>A (p.R383H)
Variant2ClinVarID: 558189
Variant2CAID: CA:2802205
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life
PMID: 23837464
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
201
Case#: Patient 20 (see Table 2), 37 weeks, 1 day (Gestational age)
DiseaseAssertion: MPS1-H/S
FamilyInfo: Sibling of Patient 19 (see Table 2)
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: 0.95 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1044C>A (p.N348K)
Variant2ClinVarID: N/A
Variant2CAID: CA:355963142
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9 (see Table 2), 37 weeks, 2 days (Gestational age)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Upper respiratory tract involvement
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA:356986
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
21
Case#: Patient 21 (see Table 2), 41 weeks, 2 days (Gestational age)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: 0.35 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.653T>C (p.L218P)
Variant1ClinVarID: 222995
Variant1CAID: CA356986
Variant2: c.943G>T (p.D315Y)
Variant2ClinVarID: N/A
Variant2CAID: CA:355962740
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
18
Case#: Patient 18 (see Table 2), 40 weeks (Gestational age)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Upper respiratory tract involvement
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.77 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1513C>G (p.R505G)
Variant2ClinVarID: 1482722
Variant2CAID: CA:355964784
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
284
Case#: Patient 28 (see Table 2), 40 weeks, 5 days (Gestational age)
DiseaseAssertion: MPS1-S
FamilyInfo: Sibling of Patient 29 (see Table 2)
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: Upper respiratory tract involvement
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.474-2A>G (new nomenclature:c.386-2A>G)
Variant1ClinVarID: 222994
Variant1CAID: CA356991
Variant2: c.1148G>A (p.R383H)
Variant2ClinVarID: 558189
Variant2CAID: CA:2802205
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
13
Case#: Patient 13 (see Table 2), 38 weeks, 3 days (Gestational age)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Upper respiratory tract involvement
CaseNotHPOs: Inguinal hernia (HP:0000023)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.43 nmol x mg-1 × hr-1
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA:356986
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
10/F
Case#: Patient 10, female, Han origin, 2.5 years old (age at diagnosis)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Hepatosplenomegaly, Airway obstruction (HP:0001263, HP:0000256, HP:0001387, HP:0001433, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Mongolian macula, Hernia (HP:0011369, HP:0100790)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.2 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.236C>T (p.A79V)
Variant1ClinVarID: 1458769
Variant1CAID: CA356987
Variant2: c.536C>G (p.T179R)
Variant2ClinVarID: 556358
Variant2CAID: CA355961718
AdditionalVariants: N/A
ParentalGenotype: Father - c.236C>T, Mother - c.536C>G. The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
11/M
Case#: Patient 11, male, Han origin, 7 years old (age at diagnosis)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: Macrocephaly, Joint stiffness, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0000256, HP:0001387, HP:0001433, HP:0100790, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Global Developmental Delay, Mongolian macula (HP:0001263, HP:0011369)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.1 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.236C>T (p.A79V)
Variant1ClinVarID: 1458769
Variant1CAID: CA234128
Variant2: c.236C>T (p.A79V)
Variant2ClinVarID: 1458769
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed by parental testing.
PreviouslyPublished N/A
12/F
Case#: Patient 12, female, Han origin, 13 years old (age at diagnosis)
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: Joint stiffness, Hepatosplenomegaly (HP:0001387, HP:0001433)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Global Developmental Delay, Macrocephaly, Mongolian macula, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0011369, HP:0100790, HP:0006536)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.0 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.536C>G (p.S633L)
Variant1ClinVarID: 556406
Variant1CAID: CA355966010
Variant2: c.536C>G (p.S633L)
Variant2ClinVarID: 556406
Variant2CAID: CA355966010
AdditionalVariants: N/A
ParentalGenotype: Father - c.536C>G, Mother - c.536C>G. The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed by parental testing.
PreviouslyPublished N/A
7/F
Case#: Patient 7, female, Han origin, 7 years old (age at diagnosis)
DiseaseAssertion: MPS1-H/S
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Hepatosplenomegaly (HP:0001263, HP:0000256, HP:0001387, HP:0001433)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: Mongolian macula, Hernia, Airway obstruction (HP:0011369, HP:0100790, HP:0006536)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.3 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1227dupG (paper says c.1225dupC but according to the variant sequence this should be c.1227dupG - a known variant)
Variant1ClinVarID: 929237
Variant1CAID: CA1139658406
Variant2: c.236C>T (p.A79V)
Variant2ClinVarID: 1458769
Variant2CAID: CA356987
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
34/M
Case#: Patient 34, male, Han origin, 10 months old (age at diagnosis)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Global Developmental Delay, Macrocephaly, Joint stiffness, Mongolian macula, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0001387, HP:0011369, HP:0001433, HP:0100790, HP:0006536)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 1.2 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.656dupG (Paper refers to the variant as c.657dupG, there is a typo in the article where all duplication variants are one base pair off)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965940
Variant2: c.623G>A (p.G208D)
Variant2ClinVarID: 554590
Variant2CAID: CA355961948
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
44/M
Case#: Patient 44, male, Han origin, 21 years old (age at diagnosis)
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: Joint stiffness (HP:0001387)
CaseHPOFreeText: N/A
CaseNotHPOs: Global Developmental Delay, Macrocephaly, Mongolian macula, Hepatosplenomegaly, Hernia, Airway obstruction (HP:0001263, HP:0000256, HP:0011369, HP:0001433, HP:0100790, HP:0006536)
CaseNotHPOFreeText: Cardiac disease
CaseEnzymeAssay: IDUA activity 1.5 nmol/h/mg protein. The normal range in Chinese controls was found to be 27.2–52 nmol/h/mg protein.
CaseUrineGAGs: Diagnosis was confirmed biochemically by the demonstration of an increased excretion of urinary dermatan sulfate and heparan sulfate.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.2T>C (p.Met1Thr)
Variant1ClinVarID: 639529
Variant1CAID: CA2801095
Variant2: c.1037T>G (p.L346R)
Variant2ClinVarID: 11927
Variant2CAID: CA256128
AdditionalVariants: N/A
ParentalGenotype: The transmission of sequence variations found in each patient was inferred by sequencing the corresponding exons of the patient's parents - confirmed in trans by parental testing.
PreviouslyPublished N/A
4
Case#: Infant 4
DiseaseAssertion: N/A
FamilyInfo: Has an older sibling who is asymptomatic, has normal urine GAGs, and shares the same genotype.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.2 nmol/h/mg; normal range, 6-71.4 nmol/h/mg
CaseUrineGAGs: 18.61 mg/mmol creatinine; normal ranges, 0-53 mg/mmol creatinine. Heparan sulfate was slightly elevated at 7.46 g/mol creatinine (normal, 0-5.71 g/mol creatinine) in 2 separate specimens.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.720C>G (p.H240Q)
Variant1ClinVarID: 1011483
Variant1CAID: CA355962130
Variant2: c.1112T>A (p.V371D)
Variant2ClinVarID: 1470032
Variant2CAID: CA355963356
AdditionalVariants: N/A
ParentalGenotype: c.720C>G (maternal); c.1112T>A (paternal)
PreviouslyPublished N/A
1
Case#: Infant 1
DiseaseAssertion: N/A
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 5.1 nmol/h/mg; normal range, 15.1-50.9 nmol/h/mg
CaseUrineGAGs: 22.6 mg/mmol creatinine; normal ranges, 0-53 mg/mmol creatinine
CaseERT: N/A
CaseBMT: N/A
Variant1: c.298A>G (p.R100G)
Variant1ClinVarID: 2058952
Variant1CAID: CA2801159
Variant2: c.300-20C>T
Variant2ClinVarID: 1415135
Variant2CAID: CA2801857
AdditionalVariants: c.1345C>A (p.H449N)
ParentalGenotype: c.298A>G (maternal); c.300-20C>T (paternal); c.1345C>A (paternal)
PreviouslyPublished N/A
4
Case#: Patient 4 was biochemically diagnosed with MPS I because they showed an increase in urinary GAGs and a reduction in IDUA activity in leukocytes. Patient 4 was diagnosed at 2 years and 7 months.
DiseaseAssertion: MPSI-H/S
FamilyInfo: N/A
CasePresentingHPOs: Coarse facies, corneal clouding, hernias, skeletal abnormalities, cardiac abnormalities, and hepatosplenomegaly (HP:0000256, HP:0007957, HP:0100790, HP:0002360, HP:0001627, HP:0001433)
CaseHPOFreeText: N/A
CaseNotHPOs: Intellectual disability, growth delay (HP:0001249, HP:0001510)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity of 6.5 nmol/mg/protein/hr. No reference range provided.
CaseUrineGAGs: 202.8 CPC unit/g creatinine. No reference range provided.
CaseERT: N/A
CaseBMT: N/A
Variant1: c.236C>T (p.A79V)
Variant1ClinVarID: 1458769
Variant1CAID: CA356987
Variant2: c.1882C>T (p.R628X)
Variant2ClinVarID: 550421
Variant2CAID: CA2802462
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
P4-IDUAFEuropeanItaly1.43.8IDUAc.246C > G/c.1716C > Gp.His82Gln/p.His572GlnMissenseMissensePseudo/VUS
Case#: P4-IDUA, F, European, Italy DiseaseAssertion: MPS1 - Pseudo/VUS FamilyInfo: CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: NBS 1.4 triplex / 3.8 single CaseUrineGAGs: CaseERT: CaseBMT: Variant1: c.246C>G Variant1ClinVarID: 92637 Variant1CAID: CA220506 Variant2: c.1716C>G Variant2ClinVarID: 1431214 Variant2CAID: CA355965272 AdditionalVariants: ParentalGenotype: PreviouslyPublished
P2-IDUAMNorth AfricaMorocco0.964.2IDUAc.246C > G/c.1757C > Tp.His82Gln/p.Ser586PheMissenseMissensePseudo/VUS
Case#: P2-IDUA, M, North Africa, Morocco DiseaseAssertion: MPS1 - Psuedu/VUS FamilyInfo: CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: NBS 0.96 triplex / 4.2 single CaseUrineGAGs: CaseERT: CaseBMT: Variant1: c.246C>G Variant1ClinVarID: 92637 Variant1CAID: 92637 Variant2: c.1757C>T Variant2ClinVarID: 571910 Variant2CAID: CA2802396 AdditionalVariants: ParentalGenotype: PreviouslyPublished
Abnormal
Case#: No additional case information provided.
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Abnormal
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1042_1062dup
Variant1ClinVarID: 2432708
Variant1CAID: CA549264534
Variant2: c.986A>G
Variant2ClinVarID: N/A
Variant2CAID: CA2802157
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Abnormal
Case#: No additional case information provided
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Abnormal
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1051G>A (p.A351T)
Variant1ClinVarID: 967585
Variant1CAID: CA2802176
Variant2: c.497G>C (p.R166T)
Variant2ClinVarID: 1388155
Variant2CAID: CA2801967
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
NP
Case#: No additional case information provided
DiseaseAssertion: Not specified
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Not performed
CaseUrineGAGs: Normal
CaseERT: N/A
CaseBMT: N/A
Variant1: c.53T>C (p.L18P)
Variant1ClinVarID: 193062
Variant1CAID: CA238566
Variant2: c.1651G>C (p.V551L)
Variant2ClinVarID: 1410776
Variant2CAID: CA2802341
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
7
Case#: Patient 7 (see Table 2), male, 15.1 years old (age at report), 6.9 years (duration of treatment), 6 surgeries
DiseaseAssertion: MPS1-HS
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0000238, HP:0002176, HP:0002360 (Hydrocephalus, spinal cord compression, sleep abnormality)
CaseNotHPOFreeText: Shunt placement, psychiatric problems
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes
CaseBMT: N/A
Variant1: (p.G256R) Potential type error, p.G256R does not exist, possible should be p.G265R as seen in Patient 8.
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
12
Case#: Patient 12 (see Table 2), female, 20.9 years old (age at report), 9.3 years (duration of treatment), 10 surgeries
DiseaseAssertion: MPS1-HS
FamilyInfo: N/A
CasePresentingHPOs: HP:0002176 (Spinal cord compression)
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0000238, HP:0002360 (Hydrocephalus, sleep abnormality)
CaseNotHPOFreeText: Shunt placement
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: (Int11-7c>t) Current HGVS nomenclature is c.1651-7C>T
Variant2ClinVarID: 1147380
Variant2CAID: CA438057995
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 11, 4 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: Sibling of patient 10
CasePresentingHPOs: Coarse facial features, recurrent infections, dysostosis multiplex, intellectual disability, hernia (HP:0000280, HP:0002719, HP:0000943, HP:0001249, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 3.6% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.531C>G (p.Phe177Leu)
Variant1ClinVarID: 2432729
Variant1CAID: CA2801983
Variant2: c.531C>G (p.Phe177Leu)
Variant2ClinVarID: 2432729
Variant2CAID: CA2801983
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 39, 1 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Joint contractures, dysostosis multiplex (HP:0002828, HP:0000943)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 3.4% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1373T>C (p.Leu458Pro)
Variant1ClinVarID: N/A
Variant1CAID: CA355964255
Variant2: c.1373T>C (p.Leu458Pro)
Variant2ClinVarID: N/A
Variant2CAID: CA355964255
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 53, 2 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, corneal clouding, recurrent infections, intellectual disability, hernia (HP:0000280, HP:0001433, HP:0007957, HP:0002719, HP:0001249, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.5% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.502G>T (p.Gly168Ter)
Variant1ClinVarID: N/A
Variant1CAID: CA355961652
Variant2: c.1402+1G>A
Variant2ClinVarID: 555490
Variant2CAID: CA355964379
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 19, 1 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures, corneal clouding, recurrent infections, dysostosis multiplex, hernia (HP:0000280, HP:0001433, HP:0002828, HP:0007957, HP:0002719, HP:0000943, HP:0100790)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.7% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.784delC (p.His262Thrfs*55)
Variant1ClinVarID: 956890
Variant1CAID: CA2802083
Variant2: c.784delC (p.His262Thrfs*55)
Variant2ClinVarID: 956890
Variant2CAID: CA2802083
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 49, 2 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, recurrent infections, dysostosis multiplex, hernia (HP:0000280, HP:0001433, HP:0002719, HP:0000943, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.7% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.(1189+1)(1190–1)(1959_?)del in the paper, unsure how to write this in current nomenclature.
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.(1189+1_1190-1)(2003?)del in the paper, unsure how to write this in current nomenclature.
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 47, 2 years old (age at report), female, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 1.8% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.(792+1_793-1)_(972+1_973-1)del in the paper, unsure how to write this in current nomenclature.
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: c.(792+1_793-1)_(972+1_973-1)del in the paper, unsure how to write this in current nomenclature.
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 46, 9 years old (age at report), female, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures (HP:0000280, HP:0001433, HP:0002828)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.0% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1898C>T (p.Ser633Leu)
Variant1ClinVarID: 556406
Variant1CAID: CA355966010
Variant2: c.1898C>T (p.Ser633Leu)
Variant2ClinVarID: 556406
Variant2CAID: CA355966010
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Hurler disease
Case#: Patient 36, 6 years old (age at report), male, Indian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Coarse facial features, hepatosplenomegaly, joint contractures, corneal clouding, recurrent infections, dysostosis multiplex, intellectual disability, hernia (HP:0000280, HP:0001433, HP:0002828, HP:0007957, HP:0002719, HP:0000943, HP:0001249, HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 2.5% (Range of residual enzyme activity: 0.0%-4.8%)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1373T>C (p.Leu458Pro)
Variant1ClinVarID: N/A
Variant1CAID: CA355964255
Variant2: c.1373T>C (p.Leu458Pro)
Variant2ClinVarID: N/A
Variant2CAID: CA355964255
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Patient 3
Case#:3. 0.7 year Male, diagnosed at 0.4 years DiseaseAssertion:MPS1H FamilyInfo:NA CasePresentingHPOs:NA CaseHPOFreeText:NA CaseNotHPOs:NA CaseNotHPOFreeText:NA CaseEnzymeAssay:Undetectable CaseUrineGAGs:NA CaseERT:NA CaseBMT:Yes, Unrelated cord blood, Post HSCT 18.2 nmol/h/mg of protein ( α-l-Iduronidase Levels) Variant1:IDUA : c.178C>T Variant1ClinVarID:655054 Variant1CAID: Variant2:IDUA: c.1205G>A Variant2ClinVarID: 11908 Variant2CAID:CA220498 AdditionalVariants: ParentalGenotype: PreviouslyPublished
younger sibling
Case#: YS of sibship 9, female, 6.7 years old (age at diagnosis), 8.6 years old (age at ERT enrollment), 6.4 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Affected OS (OS of sibship 9)
CasePresentingHPOs: HP:0007957, HP:0000943, HP:0002828 (Corneal opacity, dysostosis, joint contracture)
CaseHPOFreeText: Cardiac disease, ocular, respiratory, and musculoskeletal involvement.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - Had stabilization of mild ocular symptoms, and cardiac disease remained less severe in the mild to moderate range. Had stabilization of dysostosis multiplex and no progression of motor function delays.
CaseBMT: N/A
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
younger patient
Case#: YS of Sibship 1, male, 0.2 years old (age at diagnosis), 0.3 years old (age at ERT enrollment), 4.5 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Affected female OS (OS of sibship 1).
CasePresentingHPOs: Hernia (HP:0100790)
CaseHPOFreeText: N/A
CaseNotHPOs: HP:0007957, HP:0000943, HP:0002828 (Corneal opacity, dysostosis, joint contractures)
CaseNotHPOFreeText: Cardiac disease
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - after almost 5 years of ERT, there was no development of cardiac or musculoskeletal disease.
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
sibling who began ERT at <1 year of age
Case#: YS1 of sibship 5 (see Table 1), male, 0.1 years old (age at diagnosis), 0.3 years old (age at ERT enrollment), 7.6 years (duration of ERT)
DiseaseAssertion: MPS1-HS
FamilyInfo: Two affected siblings (OS and YS2 of sibship 5)
CasePresentingHPOs: HP:0007957 (Corneal opacity)
CaseHPOFreeText: Cardiac disease
CaseNotHPOs: HP:0000943, HP:0002828 (Dysostosis, joint contractures)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - Remained healthy, with the exception of mild ocular and cardiac symptoms. Psychomotor development remained normal and there were no limitations in ADL. Pulmonary function was between 70 and 94 % of normal at T2.
CaseBMT: N/A
Variant1: c.1469T>C (p.L490P)
Variant1ClinVarID: 11919
Variant1CAID: CA220503
Variant2: c.1469T>C (p.L490P)
Variant2ClinVarID: 11919
Variant2CAID: CA220503
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
the youngest
Case#: YS of sibship 6 (see Table 1), male, 0.6 years old (age at diagnosis), 3 years old (age at ERT enrollment), 7 years (duration of ERT)
DiseaseAssertion: MPS-HS
FamilyInfo: Two affected siblings (OS1 and OS2 of sibship 6)
CasePresentingHPOs: HP:0007957, HP:0000943, HP:0002828 (Corneal opacity, dysostosis, joint contractures)
CaseHPOFreeText: Cardiac disease, musculoskeletal symptoms
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: Yes - Pulmonary function was 70–80 % of normal and had no restrictions in ADL.
CaseBMT: N/A
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships
PMID: 26446585
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of alpha-l-iduronidase mutations causing mucopolysaccharidosis type I
PMID: 19954743
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
10 MPS I patients
Case#: MPS 1 patient
DiseaseAssertion: N/A
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.208C>T (p.Q70X)
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: c.943G>T (p.D315Y)
Variant2ClinVarID: 4539822
Variant2CAID: CA355962740
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient 3, 4 years old, Iranian
DiseaseAssertion: MPS1-H (Severe)
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity not detected
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
A novel compound mutation in alpha-L-iduronidase gene causes mucopolysaccharidosis type I
PMID: 31544795
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
D1
Case#: Patient D1, Druze religious group, located in lower Galilee.
DiseaseAssertion: MPS1-H
FamilyInfo: Both parents, as well as an aunt and uncle who had a deceased affected child, were heterozygous for the same mutation.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.192C>A (p.Y64X)
Variant1ClinVarID: 11914
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
5
Case#: Patient No. 5 (Table 1), Black race, male, 2.84 years old (age at time of gene therapy), 77 IQ score, 2.18 years since gene therapy (2 years since latest visit). An acute hypersensitivity reaction that occurred in Patient 5 on day 12 after HSPC gene therapy and concomitantly to a first administration of vancomycin was considered by the investigators to be probably related to HSPC gene therapy. The event resolved promptly after treatment with antihistamines, intravenous fluids, and glucocorticoids, with no sequelae.
DiseaseAssertion: MPS-IH
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: Yes
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1409delT (p.V470AfsX?)
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: CA-106 ID number, Table S1.1 of Supplementary Material. Male, 5 months old (age at first symptoms), 6.5 months old (age at diagnosis). Stored frozen (-20ºC) 1.3 yr
DiseaseAssertion: Severe MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: Bump on back, chronic breathing problems, moderate-severe hearing loss.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: 1351 fmol/punch
CaseERT: N/A
CaseBMT: Yes - In April 2018
Variant1: N/A
Variant1ClinVarID: N/A
Variant1CAID: N/A
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: CA-120 ID number, Table S1.1 of Supplementary Material. Female, 8 months old (age at first symptoms), 9 years and 6 months old (age at diagnosis). Stored frozen (-20ºC) 28 yr. May be the sibling of CA-119 due to closeness in ID numbers as well as having the same variants.
DiseaseAssertion: Attenuated MPS-I
FamilyInfo: N/A
CasePresentingHPOs: Ear infections (12 sets of tubes), hernia, joint contractures (HP:0410018, HP:0100790, HP:0100790)
CaseHPOFreeText: Perri Robin Syndrome, Adenoids removed (2x). Heart Valves, Spine, Contractures (No additional information provided about these symptoms).
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: 399 fmol/punch
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1651-7C>T
Variant1ClinVarID: 1147380
Variant1CAID: CA438057995
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein
PMID: 19396826
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
12/F
Case#: 12, Female, 5 months (onset), 5 years (diagnosed), 5 years (report), deceased (at 7y)
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0004322, HP:0000256, HP:0001387, HP:0002240, HP:0001744, HP:0001537, HP:0000365, HP:0000280, HP:0000943, HP:0007957 (Short Stature, Macrocephaly, Joint Stiffness, Hepatomegaly (Severe), Splenomegaly (moderate), Umbilical Hernia, Deafness (progressive), Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: Mental Development (Delayed)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.Q70X
Variant1ClinVarID: 11909
Variant1CAID: CA204563
Variant2: p.D315Y
Variant2ClinVarID: N/A
Variant2CAID: CA355962740
AdditionalVariants: p.A8, p.A20, p.Q33H, p.L118
ParentalGenotype: N/A
PreviouslyPublished N/A
9/F
Case#: 9, Female, 3-4 years (onset), 4 years (diagnosed), 20 years (report), deceased (accidentally at 21y)
DiseaseAssertion: Hurler-Scheie Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0000256, HP:0001387, HP:0002240, HP:0001744, HP:0001639, HP:001285, HP:0000158, HP:0000280, HP:0000943, HP:0007957 (Macrocephaly, Joint Stiffness (Severe and progressive), Hepatomegaly (Severe at diagnosis but none at report), Splenomegaly (mild at diagnosis and report), Hypertrophic Cardiomyopathy (Progressive), Carpal tunnel syndrome, Large Tongue, Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: Mental Development (Uneven Development at 2y; IQ 117 at 12y)
CaseNotHPOs: HP:0004322 (Short Stature)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: ERT since 18y
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.W402X
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: p.E640fs
Variant2ClinVarID: 558359
Variant2CAID: CA355966048
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
20/F
Case#: 20, Female, infancy (onset), 2 years (diagnosed), 2 years (report)
DiseaseAssertion: Hurler Syndrome
FamilyInfo: N/A
CasePresentingHPOs: HP:0004322, HP:0002240, HP:0001744, HP:0000280, HP:0000943, HP:0007957 (Short Stature, Hepatomegaly, Splenomegaly, Coarse Facial Features, Dysostosis Multiplex, Corneal Clouding)
CaseHPOFreeText: (Mental Development (delayed since early infancy), Mild LV hypertrophy, Frequent respiratory infections, Vision Impairment and Hearing Loss)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Not Provided
Variant1: p.V620F
Variant1ClinVarID: 1067173
Variant1CAID: CA355965934
Variant2: p.V620F
Variant2ClinVarID: 1067173
Variant2CAID: CA355965934
AdditionalVariants: p.R105Q/R105Q, p.N181/N181, p.A314/A314, p.A361T/A361T, p.T388/T388, p.T410/T410, p.V454I/V454I, p.R489/R489
ParentalGenotype: N/A
PreviouslyPublished N/A
Mucopolysaccharidosis type I newborn screening: Importance of second tier testing for ethnically diverse populations Kerri Bosfield, Kerri Bosfield orcid.org/0000-0001-5135-3779 Children's National Hospital, Washington, DC, USASearch for more papers by this authorDebra S. Regier, Corresponding Author Debra S. Regier dregier@childrensnational.org orcid.org/0000-0001-7525-0088 Children's National Hospital, Washington, DC, USA Correspondence Debra S. Regier, Children's National Hospital, 111 Michigan Ave NW, Washington, DC 20010, USA. Email: dregier@childrensnational.orgSearch for more papers by this authorSarah Viall, Sarah Viall Children's National Hospital, Washington, DC, USASearch for more papers by this authorRebecca Hicks, Rebecca Hicks Children's National Hospital, Washington, DC, USASearch for more papers by this authorNatasha Shur, Natasha Shur orcid.org/0000-0003-1336-747X Children's National Hospital, Washington, DC, USASearch for more papers by this authorChristina L. Grant, Christina L. Grant Children's National Hospital, Washington, DC, USASearch for more papers by this author
PMID: 33098355
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
A319V
Case#: Family 26, Pakistan
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The Scheie phenotype is characterized by aortic valve disease, corneal clouding, limited skeletal problems, but no mental retardation. This is a general assessment and not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
α-L-iduronidase activity in COS-7 cells transiently transfected with wild-type or mutagenised cDNAs. α-L-iduronidase activity: 5.2 nmol/h/mg cell protein; values are the means of two experiments.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.956C>T (p.A319V)
Variant1ClinVarID: 1683230
Variant1CAID: CA2802126
Variant2: c.956C>T (p.A319V)
Variant2ClinVarID: 1683230
Variant2CAID: CA2802126
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
740delC
Case#: Family 18, Slovenia
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The paper states that "Hurler form is characterized by skeletal abnormalities, hepatosplenomegaly and severe mental retardation" but is not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.652delC; c.740delC in the paper (old nomenclature)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965939
Variant2: c.652delC; c.740delC in the paper (old nomenclature)
Variant2ClinVarID: N/A
Variant2CAID: CA2586965939
AdditionalVariants: N/A
ParentalGenotype: Parental testing conducted, each parent was shown to carry one of the sequence changes found in their affected child.
PreviouslyPublished N/A
W402X
Case#: Family 6, UK
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The paper states that "Hurler form is characterized by skeletal abnormalities, hepatosplenomegaly and severe mental retardation" but is not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.46_57del (p.Ser16_Ala19del); in the paper it is listed as c.134del12 (old nomenclature)
Variant2ClinVarID: 92643
Variant2CAID: CA220509
AdditionalVariants: N/A
ParentalGenotype: Parental testing conducted, each parent was shown to carry one of the sequence changes found in their affected child.
PreviouslyPublished N/A
R619X
Case#: Family 8, UK
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: The paper states that "Hurler form is characterized by skeletal abnormalities, hepatosplenomegaly and severe mental retardation" but is not specific to this patient.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: The α-L-iduronidase enzyme activities in leucocytes from all patients in the study was measured using the artificial substrate 4-methylumbelliferyl α-L iduronide (Sigma). Values ranged from 0 to 2.47 nmol/h/mg protein (reference range: 28–92 nmol/h/mg protein) and did not correlate to the clinical phenotype.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1855C>T (p.R619X)
Variant2ClinVarID: 280976
Variant2CAID: CA2802455
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient 1, male, 6.9 months (age at HSCT), 4.2 months (age at ERT)
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Autoimmune hemolysis (HP:0001890)
CaseHPOFreeText: Rhinovirus pneumonitis
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.22 (at diagnosis), 55.5 (post HSCT) Units not provided.
CaseUrineGAGs: N/A
CaseERT: Yes - 83 days duration
CaseBMT: Yes - MUD (matched unrelated donor) with stem cells sourcing from the CB (cord blood)
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
patient
Case#: Patient with Hurler Syndrome. No clinical information provided.
DiseaseAssertion: MPS-IH
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Effect of small molecule eRF3 degraders on premature termination codon readthrough
PMID: 33764477
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
patient
Case#: Female, 6 months old (age of onset), 1 year old (age at report), Mauritanian descent, weight of 7.94 kg (5%), length of 75 cm (just below 50%), occipitofrontal circumference was 47 cm (95%).
DiseaseAssertion: MPS1-H
FamilyInfo: Born from healthy first cousins
CasePresentingHPOs: Eczema, mild coarse facial features, frontal bossing, depressed nasal bridge, flared nostrils, retrognathia, truncal hypotonia, Mongolian blue spot, dilated cardiomyopathy, hip dislocation (HP:0000964, HP:0000256, HP:0002007, HP:0005280, HP:0000454, HP:0000278, HP:0008936, HP:0011369, HP:0001644, HP:0002827)
CaseHPOFreeText: N/A
CaseNotHPOs: Hepatosplenomegaly (HP:0001433)
CaseNotHPOFreeText: Hands and feet were normal. A neuro-exam revealed intact cranial nerves and normal power and deep tendon reflexes were normal. Cranial computed tomography (CT)-scan and abdominal ultrasound were normal.
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: Both mother and father received WES and are confirmed heterozygous carriers of c.1598C>G (p.P533R)
PreviouslyPublished N/A
c.1709A>T
Case#: Functional assay variant with a clinical significance of being likely pathogenic.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1709A>T (p.D570V)
Variant1ClinVarID: 1980496
Variant1CAID: CA355965255
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
c.298A>G
Case#: Functional assay variant with a clinical significance of being a VUS.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.298A>G (p.R100G)
Variant1ClinVarID: 2058952
Variant1CAID: CA2801159
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
c.757G>T
Case#: Functional assay variant with a clinical significance of having conflicting interpretations.
DiseaseAssertion: MPS-I
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.757G>T (p.G253C)
Variant1ClinVarID: 554213
Variant1CAID: CA2802076
Variant2: N/A
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
distinct mutant IDUA alleles
Case#: Patient 98, Turkey, patient belong to the same geographical region as patients 86, 90, and 92
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.494-1G>A
Variant1ClinVarID: 557942
Variant1CAID: CA355961634
Variant2: c.494-1G>A
Variant2ClinVarID: 557942
Variant2CAID: CA355961634
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
missense mutations
Case#: Patient 2, Italy
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.979G>C (p.A327P)
Variant1ClinVarID: 167190
Variant1CAID: CA234128
Variant2: c.979G>C (p.A327P)
Variant2ClinVarID: 167190
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Scheie
Case#: 0.7% residual activity at 37 °C
DiseaseAssertion: MPS1-S
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 1.9 ± 0.7 nmol/mg/h IDUA activity at 37 °C
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1148G>A (p.R383H)
Variant1ClinVarID: 558189
Variant1CAID: CA2802205
Variant2: c.1148G>A (p.R383H)
ClinVarID: 558189
Variant2CAID: CA2802205
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Mutation analysis and clinical characterization of Iranianpatients with mucopolysaccharidosis type I
PMID: 31386236 Gene: IDUA Disease: MPS1 Inheritance: Autosomal recessive
5
Case#: Patient 5, born in 1991 (paper published in 2017), 10 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding, retinopathy (HP:0007957, HP:0000488)
CaseHPOFreeText: N/A
CaseNotHPOs: Cataract (HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 21.6 ng/mol (40.9 weight matched enzyme reference assay)
CaseUrineGAGs: 0.79 DS/CS
CaseERT: No
CaseBMT: Yes, Sib
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
8
Case#: Patient 8, born in 1994 (paper published in 2017), 9 months (age at first treatment), 2 years 3 months (age at last treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding, retinopathy, cataract (HP:0007957, HP:0000488, HP:0000518)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 7.14 ng/mol (56.53 weight matched enzyme reference assay)
CaseUrineGAGs: 1.24 DS/CS
CaseERT: No
CaseBMT: Yes, Sib
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.1205G>A (p.W402X)
Variant2ClinVarID: 11908
Variant2CAID: CA220498
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9, born in 2008 (paper published in 2017), 8 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 47 ng/mol (32 weight matched enzyme reference assay)
CaseUrineGAGs: 0.34 DS/CS
CaseERT: Yes
CaseBMT: Yes, Cord
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.208C>T (p.Q70X)
Variant2ClinVarID: 11909
Variant2CAID: CA204563
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
3
Case#: Patient 3, born in 2005 (paper published in 2017), 2 years and 7 months (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 86 ng/mol (60 weight matched enzyme reference assay)
CaseUrineGAGs: 0.43 DS/CS
CaseERT: Yes
CaseBMT: Yes, Sib
Variant1: c.17_24CCCGCGCC (Found to be c.17_24dup) (p.Ala9ProfsTer?)
Variant1ClinVarID: N/A
Variant1CAID: CA645372294
Variant2: c.1871A>T (p.Asp624Val)
Variant2ClinVarID: N/A
Variant2CAID: CA355965955
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
11
Case#: Patient 11, born in 2003 (paper published in 2017), 1 year (age at first treatment)
DiseaseAssertion: MPSI-H
FamilyInfo: N/A
CasePresentingHPOs: Corneal clouding (HP:0007957)
CaseHPOFreeText: N/A
CaseNotHPOs: Retinopathy, cataract (HP:0000488, HP:0000518)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 71.98 ng/mol (10.86 weight matched enzyme reference assay)
CaseUrineGAGs: 0.38 DS/CS
CaseERT: Yes
CaseBMT: Yes, Cord
Variant1: c.1205G>A (p.W402X)
Variant1ClinVarID: 11908
Variant1CAID: CA220498
Variant2: c.208C>T (p.Q70X)
Variant2ClinVarID: 11909
Variant2CAID: CA204563
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
5/m
Case#: Patient 5, male, 17.5 months (age at diagnosis), 21.5 months (age at HSCT), 5 MRI + neuropsychological observations over the course of 10 years.
DiseaseAssertion: MPS-1H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 37.2 nmol/h/mg (Normal values: 11-43 nmol/h/mg)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: Yes
Variant1: c.1166_1171dup (p.A389_M390dup)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965963
Variant2: c.1166_1171dup (p.A389_M390dup)
Variant2ClinVarID: N/A
Variant2CAID: CA2586965963
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Pt 7, age is 13 months (proband can be found in Table 1)
DiseaseAssertion: Hurler syndrome, mucopolysaccharidosis type IH, MPS IH, MPS type I
FamilyInfo: No family information provided
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: In methods it is stated that an IDUA activity assay was conducted on cartilaginous pellets generated from patient-derived bone marrow stromal cells at 5 weeks. However, results of the IDUA activity assays are not stated.
CaseUrineGAGs: "Significantly higher levels of GAGs in MPS IH compared with HD pellets at.1 week of chondrogenic differentiation, thus indicating that GAG accumulation in MPS IH can be seen during cell condensation and early differentiation stages." Total GAG content for each sample in ug GAG/ug DNA shown in Figure 4 graphs.
CaseERT: Don't know
CaseBMT: Don't know
Variant1: p.Q70X
Variant1ClinVarID:
Variant1CAID: PA3044620172
Variant2: c.398_403del6
Variant2ClinVarID: 863830
Variant2CAID: CA2801912
AdditionalVariants: No additional variants mentioned
ParentalGenotype: No parental information provided
PreviouslyPublished: No mention of being previously published
Case#: Pt 4, age is 12 months (proband can be found in Table 1)
DiseaseAssertion: Hurler syndrome, mucopolysaccharidosis type IH, MPS IH, MPS type I
FamilyInfo: No family information provided
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText:
CaseEnzymeAssay: In methods it is stated that an IDUA activity assay was conducted on cartilaginous pellets generated from patient-derived bone marrow stromal cells at 5 weeks. However, results of the IDUA activity assays are not stated.
CaseUrineGAGs: "Significantly higher levels of GAGs in MPS IH compared with HD pellets at.1 week of chondrogenic differentiation, thus indicating that GAG accumulation in MPS IH can be seen during cell condensation and early differentiation stages." Total GAG content for each sample in ug GAG/ug DNA shown in Figure 4 graphs.
CaseERT: Don't know
CaseBMT: Don't know
Variant1: p.P496R
Variant1ClinVarID: 496861
Variant1CAID: CA2802275
Variant2: p.P496R
Variant2ClinVarID: 496861
Variant2CAID: CA2802275
AdditionalVariants: No additional variants mentioned
ParentalGenotype: No parental information provided
PreviouslyPublished: No mention of previously being published
13
Case#: 13, Male, 0.8 years (diagnosed), 1.6 years (report), 7.2 kg (weight), 71 cm (height), Iranian
DiseaseAssertion: Scheie Syndrome
FamilyInfo: Parents are not consanguineous
CasePresentingHPOs: HP:0001249, HP:0001999, HP:0100790 (Mental Retardation, Facial Dysmorphic Features, Hernia)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea
CaseNotHPOs: HP:0000943, HP:0001387, HP:0000365, HP:0007957, HP:0000238 (Multiple Dysostosis, Joint Stiffness, Deafness, Corneal Opacity, Hydrocephalus)
CaseNotHPOFreeText: Cardiac Manifestations
CaseEnzymeAssay: IDUA activity 0.75 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 7.4 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: p.S157P
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
21
Case#: 21, Female, 0.8 years (diagnosed), 2.8 years (report), 7.5 kg (weight), 80 cm (height), Iranian
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Parents are consanguineous
CasePresentingHPOs:HP:0001249, HP:0001999, HP:0000943, HP:0001387, HP:0100790, HP:0000365, HP:0007957, HP:0000238 (Mental Retardation, Facial Dysmorphic Features, Multiple Dysostosis, Joint Stiffness, Hernia, Deafness, Corneal Capacity, Hydrocephalus)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea, Cardiac Manifestations (mitral stenosis)
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: IDUA activity 0.98 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 10.5 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: Not Provided
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
7
Case#: 7, Female, 0.7 years (diagnosed), 12.9 years (report), 14.2 kg (weight), 97 cm (height), Iranian
DiseaseAssertion: Hurler-Scheie Syndrome
FamilyInfo: Parents are consanguineous
CasePresentingHPOs: HP:0001249, HP:0001999, HP:0000943, HP:0001387, HP:0100790, HP:0000365, HP:0000238 (Mental Retardation, Facial Dysmorphic Features, Multiple Dysostosis, Joint Stiffness, Hernia, Deafness, Hydrocephalus)
CaseHPOFreeText: HM/HSM, Chronic Rhinorrhea
CaseNotHPOs: HP:0007957 (Corneal Capacity)
CaseNotHPOFreeText: Cardiac Manifestations
CaseEnzymeAssay: IDUA activity 0.86 (μmol/spot.20h)
CaseUrineGAGs: Quantitative urinary GAG 10.11 (mg/gCr)
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Sanger Sequencing
Variant1: p.G84R
Variant2: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished: N/A
3.3.1. Severe patients There were 115 individual genotypes represented in the 380 patients with a severe phenotype and two reported alleles; 31 genotypes were recurrent and 84 genotypes unique (Table 3). The most common genotypes in severe patients were W402X/W402X (109/380; 28.7%), W402X/Q70X (61/380; 16.1%) and Q70X/Q70X (24/380; 6.3%). In total, these two nonsense variants defined the genotypes of 51% (194/380) of severe patients. Of severe patients, 67.6% (257/380) were either homozygous or compound heterozygous for two variants predicted to severely disrupt gene transcription or translation (eg, nonsense variants, frameshifts, consensus splice site disruption or initiator codon variants). No clinically diagnosed attenuated patients were homozygous or compound heterozygous for such variants. Of the remaining 123 severe patients, 76 comprised 19 recurrent genotypes (Table 3) with the remaining 47 patients (12.6%) having unique genotypes (listed in Table S1). Thirty‐seven of the 84 unique genotypes identified in severe patients were compound heterozygous with two severe variants (as defined above) and were comprised of 34 separate severe variants (listed in Table S1). There were nine missense recurrent variants and one intronic recurrent variant that were exclusively seen in severe patients (Table 5A).
Case#: Severe MPS1 patients
DiseaseAssertion: Severe MPS I
FamilyInfo: n/a, "neither the laboratory method used to determine the sequence variants nor whether parental testing confirmed the inheritance or phase of the variants is captured by the Registry"
CasePresentingHPOs:
CaseHPOFreeText: "All patients enrolled in the Registry have confirmation of MPS I diagnosis by either mutation analysis or measurement of IDUA levels."
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: n/a
GenotypingMethod: n/a
PreviouslyPublished: possible since this is a multinational registry
Variant: c.1728-1G>C/Q70X
ClinVar: 556064
CAID: CA355965306
SupplementalData: Table S1 has the genotypes listed
A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
PMID: 24053568
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
10
Case#: Patient 10 (see Table 1), 8 years old - deceased (age at report), 5 years old (age at onset), female, height of 107 cm, weight of 19 kg, located at Nfidha: Industrial region
DiseaseAssertion: MPS1 - severe
FamilyInfo: Parents were 1st cousins (see Table 2), aged 42 yrs (M) and 50 yrs (F).
CasePresentingHPOs: HP:0004322, HP:0001999, HP:0010864, HP:0002240 (Short stature, facial dysmorphia, severe intellectual disability, hepatomegaly)
CaseHPOFreeText: Pulmonary and cardiac deficiency.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA:256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA:256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
11
Case#: Patient 11 (see Table 1), 6 years old (age at report), 1 year old (age at onset), female, height of 120 cm, weight of 20 kg, located in Tunis: Industrial region
DiseaseAssertion: MPS1 - mild
FamilyInfo: Parents were 2nd cousins (see Table 2), aged 37 yrs (M) and 44 yrs (F).
CasePresentingHPOs: HP:0004322, HP:0001999, HP:0030799, HP:0001537 (Short stature, facial dysmorphia, scaphocephaly, umbilical hernia)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.09 μKat/kg
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1733T>A (p.L578Q)
Variant1ClinVarID: N/A
Variant1CAID: CA355965319
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
6/M
Case#: Patient 6, male, Russian
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: Severe intellectual disability, corneal clouding, skeletal deformities, hepatosplenomegaly (HP:0010864, HP:0007957, HP:0000924, HP:0001433)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.06 nmol/mg/h (reference range 135 ± 57 nmol/mg/h)
CaseUrineGAGs: 238.7 mg GAG/mmol/creatinine (reference range 6.17 ± 3.79 mg GAG/mmol creatinine)
CaseERT: No
CaseBMT: No
Variant1: c.1162dupA (p.Thr388Asnfs*11)
Variant1ClinVarID: N/A
Variant1CAID: CA2586965961
Variant2: c.1162dupA (p.Thr388Asnfs*11)
Variant2ClinVarID: N/A
Variant2CAID: CA2586965961
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
18
Case#: Patient 18, male, 2 years (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family present for this patient.
CasePresentingHPOs: Corneal clouding, coarse facial features, dystosis multiplex, global developmental delay, hepatomegaly, joint stiffness, Mongolian blue spots, splenomegaly (HP:0007957, HP:0000256, HP:0000943, HP:0001263, HP:0002240, HP:0001387, HP:0011369, HP:0001744)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1096_1099delACCG (p.Thr366Argfs*73)
Variant1ClinVarID: 1065522
Variant1CAID: CA2499217017
Variant2: c.1096_1099delACCG (p.Thr366Argfs*73)
Variant2ClinVarID: 1065522
Variant2CAID: CA2499217017
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
9
Case#: Patient 9, female, 1 year (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family present for this patient.
CasePresentingHPOs: Corneal clouding, coarse facial features, dysostosis multiplex, global developmental delay, hepatomegaly, joint stiffness, splenomegaly, recurrent respiratory infections, umbilical hernia (HP:0007957, HP:0000256, HP:0000943, HP:0001263, HP:0002240, HP:0001387, HP:0001744, HP:0002205, HP:0001537)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.362T>C (p.L121P)
Variant1ClinVarID: 1343382
Variant1CAID: CA355961174
Variant2: c.362T>C (p.L121P)
Variant2ClinVarID: 1343382
Variant2CAID: CA355961174
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
7
Case#: Patient 7, male, 1 month (age at presentation).
DiseaseAssertion: MPS1-H
FamilyInfo: Consanguinity in the family not present for this patient. Family conducted a prenatal diagnosis on the next pregnancy and CVS to be unaffected
CasePresentingHPOs: Corneal clouding, coarse facial features, dysostosis multiplex, global developmental delay, hepatomegaly, joint stiffness, splenomegaly, umbilical hernia (HP:0007957, HP:0000256, HP:0000943, HP:0001263, HP:0002240, HP:0001387, HP:0001744, HP:0001537)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.362T>C (p.L121P)
Variant1ClinVarID: 1343382
Variant1CAID: CA355961174
Variant2: c.362T>C (p.L121P)
Variant2ClinVarID: 1343382
Variant2CAID: CA355961174
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case#: Patient #1 (see Table 2), male, 6 months old (age at diagnosis), 7 years old (age at report)
DiseaseAssertion: MPS I
FamilyInfo: Born from a consanguineous marriage
CasePresentingHPOs: Scoliosis, developmental delay, short stature, macrocephaly, coarse facial features, hepatomegaly (HP:0002650, HP:0001263, HP:0004322, HP:0000256, HP:0000256, HP:0002240)
CaseHPOFreeText: Irregular chest, respiratory problems
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: α-L-iduronidase 1.18 nmol/spot. The activity of this enzyme is below its reference (450–2600 nmol/spot).
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.469T>C (p.S157P)
Variant1ClinVarID: N/A
Variant1CAID: CA355961573
Variant2: c.469T>C (p.S157P)
Variant2ClinVarID: N/A
Variant2CAID: CA355961573
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
204
Case#: 204 14.8 yrs male, age at initial diagnosis 5 yrs DiseaseAssertion: MPS IH-S FamilyInfo:Nil CasePresentingHPOs: CaseHPOFreeText: CaseNotHPOs: CaseNotHPOFreeText: CaseEnzymeAssay: IDUA activity: low leukocyte IDUA enzyme activity CaseUrineGAGs: CaseERT: 9 yrs on ERT, then study drug, valanafusp alpha, also called AGT-181 for 12 months
CaseBMT: No PreviouslyPublished Don't know Variant1:p.R48del Variant1ClinVarID: 1518010 Variant1CAID: Variant2:p.P533R Variant2ClinVarID: 11910 Variant2CAID: CA256112
105
Case#: Pt 105 , Age 30 years, Female, DiseaseAssertion: MPS1 Scheie syndrome. FamilyInfo: NA CasePresentingHPOs: NA CaseHPOFreeText: NA CaseNotHPOs: NA CaseNotHPOFreeText: NA
CaseEnzymeAssay: Low leukocyte IDUA enzyme activity CaseUrineGAGs: NA CaseERT: No CaseBMT: No Variant1: p.R383H Variant1ClinVarID: 558189 Variant1CAID: Variant2:p.W402X Variant2ClinVarID: 11908 Variant2CAID: CA220498 AdditionalVariants: NA ParentalGenotype: NA PreviouslyPublished:NA
PKMPS1P3
Case#: PKMPS1P3, 6 months old (age at presentation), female, Pakastani, born full term through C-section
DiseaseAssertion: MPS-I
FamilyInfo: Born to consanguineous parents
CasePresentingHPOs: Abdominal distension (at 6 months), difficulty breathing, macrocephaly, coarse facial features, hernia, cardiomyopathy, recurrent respiratory infections, recurrent ear infections, joint contractures (HP:0003270, HP:0002094, HP:0000256, HP:0000256, HP:0100790, HP:0001638, HP:0002788, HP:0410018, HP:0100790)
CaseHPOFreeText: Abnormal spine position. The liver span was 10 cm, having soft to firm consistency. The spleen was palpable and soft. Bone pains. X-ray of the skull showed reverse J-shaped sella sutural diastasis, and the X-ray of the hand showed proximal tapering Q metatarsal. Thick broad arc-shaped ribs, thick skull calvarium, with apparently enlarged cardiac size was observed in the chest X-ray.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.314G>A (p.R105Q)
Variant1ClinVarID: 92641
Variant1CAID: CA145881
Variant2: c.314G>A (p.R105Q)
Variant2ClinVarID: 92641
Variant2CAID: CA145881
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
PKMPS1P1
Case#: PKMPS1P1, 4 years old (age at presentation), female
DiseaseAssertion: MPS-I
FamilyInfo: Born to a consanguineous couple
CasePresentingHPOs: Joint stiffness, coarse facial features, dysostosis multiplex, hernia (HP:0001387, HP:0000256, HP:0000943, HP:0100790)
CaseHPOFreeText: Difficulty walking, limitation in the range of movements of joints. Failure to gain height and weight.
CaseNotHPOs: Developmental delay (HP:0001263)
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.1598C>G (p.P533R)
Variant1ClinVarID: 11910
Variant1CAID: CA256112
Variant2: c.1598C>G (p.P533R)
Variant2ClinVarID: 11910
Variant2CAID: CA256112
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
1
Case#: No additional case information provided.
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.653T>C (p.L218P)
Variant1ClinVarID: 222995
Variant1CAID: CA356986
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA356986
AdditionalVariants: In the paper an additional variant is listed on the same allele as "G387 + 6c->t". It seems that the current nomenclature for this variant is "c.299+6C>T". This variant is classified as benign by the LD VCEP.
ParentalGenotype: N/A
PreviouslyPublished N/A
18-year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I
PMID: 36333985
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
10
Case#:Subject 10 : 23 years male, age of onset unknown DiseaseAssertion:MPS1 FamilyInfo:NA CasePresentingHPOs:NA CaseHPOFreeText:recieved Zinc-finger nuclease(ZFN) based in vivo genome editing as part of Study SB-318-1502, one time IV administration.Monitored by Iduronidase enzyme levels and Urine Heparan sulfate levels durinng enzyme withdrawal. ERt recommenced later. CaseNotHPOs:NA CaseNotHPOFreeText:NA CaseEnzymeAssay:Iduronidase 1.20 nmol/mL/h (normal: 6–71.4 nmol/h/mg) CaseUrineGAGs: CaseERT: <br /> CaseBMT:NA Variant1: IDUA c.386-2A>G Variant1ClinVarID: 222994 Variant1CAID: CA356991 Variant2: IDUA c.1898C>T Variant2ClinVarID: 556406 Variant2CAID: AdditionalVariants:NA ParentalGenotype:NA PreviouslyPublishedNA
Case#: Patient is from The Netherlands
DiseaseAssertion: MPSI-H
FamilyInfo: Patient has consanguinity between parents.
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.653T>C (p.L218P)
Variant1ClinVarID: 222995
Variant1CAID: CA356986
Variant2: c.653T>C (p.L218P)
Variant2ClinVarID: 222995
Variant2CAID: CA356986
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
MPS I_Case 01
Case#: MPS I_Case 01, male newborn
DiseaseAssertion: MPS type I, MPS I, MPS-I, attenuated MPS I
FamilyInfo: MPS I_Case 01 and MPS I_Case 05 are siblings
CasePresentingHPOs:
CaseHPOFreeText:
CaseNotHPOs:
CaseNotHPOFreeText: This proband is believed to be an affected MPS-patient however, the proband did not have any obvious clinical symptoms to date (up to two years of age). The paper states that this attenuated MPS I case will need a long term follow up.
CaseEnzymeAssay: Proband identified by newborn screening. alpha-L-iduronidase activity in dried blood spot sample is 0.42 umole/L/Hr; this is below the study’s DBS enzyme activity cutoff value of 3 umol/L/h
CaseUrineGAGs: Urine DMB GAG ratio is 107 mg/mmol creatinine. 10.9 ug/ml dermatan sulfate in urine (<0.41 ug/ml is the reference cutoff for dermatan sulfate in this study). 2.67 ug/ml heparan sulfate in urine (<0.8 ug/ml is the reference cutoff for heparan sulfate in this study). 7/75 ug/ml keratan sulfate in urine.
CaseERT: Don’t know (would assume no since the proband is a newborn)
CaseBMT: Don’t know (would assume no since the proband is a new born)
Variant1: c.300–3C>G
Variant1ClinVarID: 551563
Variant1CAID: CA549265042
Variant2: c.1874A>C, p.Y625S
Variant2ClinVarID: 2910181
Variant2CAID: CA355965961
AdditionalVariants: No additional variants are mentioned
ParentalGenotype: No parental testing results are available
PreviouslyPublished No statement from the author indicating the proband is previously published. Since this is a newborn study, I strongly believe this is the proband’s first time being published.
310.423 (5.1)7.9DS 2.7heterozygous PD: c.235G>A; p.A79TNot examined at UNC-CHHS 2.5heterozygous PD: c.296C>T; p.T99Iheterozygous PD: c.667G>A; p.D223N
Case#:Patient Sample unique ID 31, Infant screened positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
DiseaseAssertion:None
FamilyInfo:None
CasePresentingHPOs:None
CaseHPOFreeText:None
CaseNotHPOs:None
CaseNotHPOFreeText: Normal examination at follow up after screening positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
CaseEnzymeAssay: IDUA activity 0.423 (7.9) umol/L/h (%DMA) during new born screening through dried blood spot (plasma) and 7.9 pmol/punch/h Confirmatory IDUA enzyme
CaseUrineGAGs: DS 2.7 g/mol creatinine and HS 2.5 g/mol creatinine (Normal)
CaseERT:No
CaseBMT:No
Variant1:homozygous PD: c.235G>A; p.A79T (Normal examination)
Variant1ClinVarID:41682
Variant1CAID: CA000358
Variant2: homozygous PD: c.296C>T; p.T99I
Variant2ClinVarID:53610
Variant2CAID:CA326991
AdditionalVariants:None
ParentalGenotype:None provided
PreviouslyPublished:N/A
580.413 (5.3)8.7N/A§heterozygous PD: c.235G>A; p.A79TNormal examinationheterozygous PD: c.296C>T; p.T99Iheterozygous PD: c.667G>A; p.D223N
Case#:Patient Sample unique ID 58, Infant screened positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
DiseaseAssertion:None
FamilyInfo:None
CasePresentingHPOs:None
CaseHPOFreeText:None
CaseNotHPOs:None
CaseNotHPOFreeText: Normal examination at follow up after screening positive at birth (specimens with activity ≤15% of the DMA for enzyme activity and a CLIR screening algorithm result of indeterminate or MPS I)
CaseEnzymeAssay: IDUA activity 0.413 (8.7) umol/L/h (%DMA) during new born screening through dried blood spot (plasma) and 8.7 pmol/punch/h Confirmatory IDUA enzyme
CaseUrineGAGs: N/A (Family refused to collect additional urine specimen.)
CaseERT:No
CaseBMT:No
Variant1:homozygous PD: c.235G>A; p.A79T (Normal examination)
Variant1ClinVarID:41682
Variant1CAID: CA000358
Variant2: homozygous PD: c.296C>T; p.T99I
Variant2ClinVarID:53610
Variant2CAID:CA326991
AdditionalVariants: heterozygous PD: c.667G>A; p.D223N (ClinVarID: 2220838, CAID: CA363422841)
ParentalGenotype:None provided
PreviouslyPublished:N/A
1/m
Case#: 1, Male, Han Chinese
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0001249, HP:0007957, HP:0001433 (Mental Retardation (severe), Corneal Clouding, Hepatosplenomegaly)
CaseHPOFreeText: Skeletal Deformities
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0 Leukocyte IDUA activity (nmol/h/mg protein) (isolated leukocytes in the latter)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Using the artificial substrate 4-methyl-umbelliferyl α-L-iduronide (Sigma)
Variant1: c.1190-1G>A
Variant1ClinVarID: 1204494
Variant1CAID: CA355963511
Variant2: Not Identified
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
8/m
Case#: 8, Male, Han Chinese
DiseaseAssertion: Hurler Syndrome
FamilyInfo: Not Provided
CasePresentingHPOs: HP:0001249, HP:0007957, HP:0001433 (Mental Retardation (severe), Corneal Clouding, Hepatosplenomegaly)
CaseHPOFreeText: Skeletal Deformities
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0 Leukocyte IDUA activity (nmol/h/mg protein) (isolated leukocytes in the latter)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
GenotypingMethod: Using the artificial substrate 4-methyl-umbelliferyl α-L-iduronide (Sigma)
Variant1: c.792+1G>T
Variant1ClinVarID: N/A
Variant1CAID: CA355962278
Variant2: Not identified
Variant2ClinVarID: N/A
Variant2CAID: N/A
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome
PMID: 25116402
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Whole paternal uniparental disomy of chromosome 4 with a novel homozygous IDUA splicing variant, c.159‐9T>A, in a Chinese patient with mucopolysaccharidosis type I
PMID: 39132856
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Case#: Patient 2, 12 years old, Iranian
DiseaseAssertion: MPS1-S (Attenuated)
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: 0.3 µmol/g.h (Normal ranges: 10-50 µmol/g.h)
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.401G>T (p.G134V)
Variant1ClinVarID: N/A
Variant1CAID: CA355961317
Variant2: c.401G>T (p.G134V)
Variant2ClinVarID: N/A
Variant2CAID: CA355961317
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Differences in MPS I and MPS II Disease Manifestations
PMID: 34360653
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Case#: Patient 2, Turkish
DiseaseAssertion: MPS1-H
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.192C>A (p.Y64X)
Variant1ClinVarID: 11914
Variant1CAID: CA256113
Variant2: c.979G>C (p.A327P); Table states c.1067G>C instead of c.979G>C. This variant is not in ClinVar or has a CAID. Assuming there is a typo and this is c.979G>C
Variant2ClinVarID: 167190
Variant2CAID: CA234128
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree
PMID: 31758674
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome
PMID: 25558755
Gene: IDUA
Disease: MPS1
Inheritance: Autosomal recessive
infant’s
Case#: Infant (Pregnancy was terminated at 35 gestational weeks due to severe MPS I diagnosis, weight of 3140 g (94th percentile), length of 48 cm (80th percentile), occipitofrontal circumference of 34 cm (83rd percentile).
DiseaseAssertion: MPS1
FamilyInfo: Proband 1's mother and father were not consanguineous, their phenotype was normal, and they had no significant personal or family histories. Mother had previously had given birth to a healthy infant.
CasePresentingHPOs: Single umbilical artery, hepatosplenomegaly, hepatomegaly, coarse facial features, broad nasal tip, micrognathia, thin upper lip vermilion, hypertelorism, plagiocephaly (HP:0001195, HP:0001433, HP:0002240, HP:0000280, HP:0000455, HP:0000347, HP:0000219, HP:0000316, HP:0001357)
CaseHPOFreeText: Dysmorphic features (including a long and broad philtrum), a few echogenic spots in the liver, spleen, peritoneum, and thymus, hepatic overhang of 4 cm, microretrognatism, full and drooping cheeks, large, badly hemmed ears with bulky lobes, bulging eyes, marked suborbital folds, and micro vacuolized appearance of Hofbauer cells.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: Deficiency in α-L-iduronidase activity. Measure value was 0.3 µkat/kg with a laboratory control of 33.8 µkat/kg.
CaseUrineGAGs: N/A
CaseERT: N/A
CaseBMT: N/A
Variant1: c.590G>A (p.G197D)
Variant1ClinVarID: 554670
Variant1CAID: CA91167598
Variant2: c.1139dup (p.L381Afs*18)
Variant2ClinVarID: 3340107
Variant2CAID: CA3046517234
AdditionalVariants: N/A
ParentalGenotype: c.590G>A (inherited from the mother), c.1139dup (inherited from the father)
PreviouslyPublished N/A
patients
Case#: Patient 1, 1-year old at the start of ERT
DiseaseAssertion: MPS1-H - confirmed diagnosis of MPS 1 by enzymatic and mutation analysis
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CaseEnzymeAssay: N/A
CaseUrineGAGs: Urine GAGs are displayed in a figure and show the level at the start of ERT to 24-months later. At the start, urine GAGs appear to be slightly above 100 mg/mmol creatinine. After 24-months they decreased to be slightly below 50 mg/mmol creatinine. Normal values for >2-year olds are 8-20 mg/mmol creatinine.
CaseERT: Yes - started at 1-year old and was given once every week
CaseBMT: No
Variant1: c.494-1G>A (in the paper, the variant is labeled as IVS4-1G>A)
Variant1ClinVarID: 557942
Variant1CAID: CA355961634
Variant2: c.494-1G>A (in the paper, the variant is labeled as IVS4-1G>A)
Variant2ClinVarID: 557942
Variant2CAID: CA355961634
AdditionalVariants: N/A
ParentalGenotype: N/A
PreviouslyPublished N/A
Case 1
Case1: 17 month onset
DiseaseAssertion: Noncompaction of the ventricular myocardium
FamilyInfo: No known family history of heart disease or sudden cardiac death, Has two sisters with the same MYH7 variant and similar phenotypes, See Fig 3 for pedigree
CasePresentingHPOs: HP:0001279, HP:0001635, HP:0012818, HP:0031295, HP:0030718, HP:0005133, HP:0005180, HP:0001653, HP:0001723, HP:0002092, HP:0004890, HP:0030876, HP:0005168 (Syncope, Heart failure, Biventricular noncompaction cardiomyopathy, Left atrial enlargement, Right atrial enlargement, Right ventricular dilation, Tricuspid regurgitation, Mitral regurgitation, Restrictive cardiomyopathy, Pulmonary arterial hypertension, Elevated pulmonary artery pressure, Increased pulmonary capillary wedge pressure, Elevated right atrial pressure)
HPOsFreeText: Both cardiac ventricles had a coarsely trabeculated and spongy appearance in posterior wall, lateral wall, apical segments, and right ventricle, LVEF at 51%, Short E-wave deceleration time at the transmitral level (85 msec) with a high E/A ratio (2.1), Ratio between the thickness of the noncompacted layer and the myocardial layer was 3.4:1, Underwent cardiac catheterization, Left ventricular systolic pressure and end-diastolic pressure were 95 mmHg and 37 mmHg respectively, Pulmonary vascular resistance was 4.0 Wood Unit m^2
CaseNotHPOs: N/A
NotHPOsFreeText: Normal left ventricle end-diastolic volume (110%), No other congenital heart disease
CaseAddInfo: Died at age 2 yrs of advanced heart failure
CasePreviousTesting: TruSight One sequencing panel was used for testing (Illumina)
CaseGenotypingMethod: Blood samples were collected from the proband and his siblings and genomic DNA was extracted. Target enrichment was performed using the TruSight One sequencing panel (Illumina). Analysis was annotated and filtered, after which the MYH7 pathogenic variant was confirmed using PCR and Sanger sequencing.
Variant: NM_000257.4(MYH7):c.5740G>A (p.Glu1914Lys)
ClinVar: 43088 https://www.ncbi.nlm.nih.gov/clinvar/variation/43088/
gnomAD: Not in gnomAD
MultipleGeneVariants
(1) PLEC Variant
Variant: NM_000445.4:c.3005-8T>C
CAID: CA187619061 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA187619061
gnomAD: Not in gnomAD
The proband (II-9)
CaseII-9: Male, 38 years diagnosis, China, Asian
DiseaseAssertion: Hypertrophic cardiomyopathy
FamilyInfo: Proband's father (I-1) and mother (I-2) had histories of mild episodes of dizziness, no other symptoms reported in the other family members
CasePresentingHPOs: HP:0001279, HP:0001712, HP:0001639 (Syncope, Left ventricular hypertrophy, Hypertrophic cardiomyopathy)
HPOsFreeText: Heart rate 62 bpm, PR interval 172 ms, QRS complex duration 88 ms, Diffuse repolarization changes with a late-onset inverted T-wave pattern, LVMI 109.55 g/m2, MLVWT 24 mm, Ejection Fraction 70%
CaseNotHPOs: HP:0030148 (Heart murmur)
NotHPOsFreeText: N/A
CaseAddInfo: N/A
CasePreviousTesting: See Table 1
CaseGenotypingMethod: Genomic DNA was extracted from blood and amplified. It was then subjected to a sequencing panel with an Illumina sequencer based on the 96 genes related to cardiac function. All readings were aligned, with any variants confirmed by Sanger sequencing and filtered for pathogenicity.
Variant: NM_000257.3:c.5151T>A (p.His1717Gln)
CAID: CA389036862 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000257.3%3Ac.5151T%3EA
gnomAD: Not in gnomAD
Multiple Gene Variants:
KCNQ1 Variant
Variant: NM_000218.2:c.568C>T (p.Arg190Trp)
ClinVar: 53070 https://www.ncbi.nlm.nih.gov/clinvar/variation/53070/
gnomAD: Latino 2.896e-5, Overall 4.011e-6 https://gnomad.broadinstitute.org/variant/11-2591948-C-T
MYLK2 Variant
Variant: NM_033118.3:c.970A>G (p.Lys324Glu)
ClinVar: CA408526793 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_033118.3%3Ac.970A%3EG
gnomAD: African 6.453e-5, Overall 4.087e-6 https://gnomad.broadinstitute.org/variant/20-30412153-A-G
TMEM70 Variant
Variant: NM_017866.5:c.440T>C (p.Ile147Thr)
ClinVar: 571761 https://www.ncbi.nlm.nih.gov/clinvar/variation/571761/
gnomAD: East Asian 4.893e-4, Overall 3.579e-5 https://gnomad.broadinstitute.org/variant/8-74893513-T-C
9
Case9: Male, 46 years onset, 48 years diagnosis, Italy
HPOsFreeText: See Group Phenotypes, ERT started at 48, GAA Activity at ~7.5 pmol/min/mg before ERT and ~11 after
GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.525delT (p.Glu176Argfs*45)
ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
CaseAddInfo: Late Onset Pompe Disease
8
Case8: Male, 16 years onset, 36 years diagnosis, Italy
HPOsFreeText: See Group Phenotypes, ERT started at 36, GAA Activity at ~5 pmol/min/mg before ERT and ~13 after
GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.525delT (p.Glu176Argfs*45)
ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
CaseAddInfo: Late Onset Pompe Disease
18
Case18: Female, 50 years onset, 53 years diagnosis, Italy
HPOsFreeText: See Group Phenotypes, ERT started at 56, GAA Activity at ~6 pmol/min/mg before ERT and ~9 after
GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.1465G>A (p.Asp489Asn)
ClinVar: 92465 https://www.ncbi.nlm.nih.gov/clinvar/variation/92465/
gnomAD: European (Finnish) 4.621e-5, Overall 1.195e-5 http://gnomad.broadinstitute.org/variant/17-78084553-G-A
CaseAddInfo: Late Onset Pompe Disease
3
Case3: Male, 30 years onset, 66 years diagnosis, Italy
HPOsFreeText: See Group Phenotypes, ERT started at 67, GAA Activity at ~8 pmol/min/mg before ERT and ~10 after
GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.1927G>A (p.Gly643Arg)
ClinVar: 4023 https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/
gnomAD: European (Non-Finnish) 3.667e-5, Overall 2.479e-5 http://gnomad.broadinstitute.org/variant/17-78086713-G-A
CaseAddInfo: Late Onset Pompe Disease
1
Case1: Male, 21 years onset, 31 years diagnosis, Italy
HPOsFreeText: See Group Phenotypes, ERT started at 31, GAA Activity at ~7.5 pmol/min/mg before ERT and ~8 after
GroupGenotypingMethod: PCR Amplification and GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.1927G>A (p.Gly643Arg)
ClinVar: 4023 https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/
gnomAD: European (Non-Finnish) 3.667e-5, Overall 2.479e-5 http://gnomad.broadinstitute.org/variant/17-78086713-G-A
CaseAddInfo: Late Onset Pompe Disease
7
Patient7: 71yo
CasePresentingHPOs: HP:0003325, HP:0002093, HP:0002315, HP:0004887, HP:0000822, HP:0003141, HP:0002870, HP:0020038
HPOsFreeText: morning headache, GAA = 7%, BMI = 28.3, temporo-insular lacunes
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 18yr disease duration, variants in trans
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.2530_2541del
CAID: CA658795292, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA658795292
gnomAD: n/a
5
Patient5: 36yo
CasePresentingHPOs: HP:0003325, HP:0002093, HP:0001513, HP:0002637
HPOsFreeText: GAA = 4.6%, BMI = 35.1, normal CTA, right temporal pole ischaemia
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 4yr disease duration, variants in trans
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.2530_2541del
CAID: CA658795292, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA658795292
gnomAD: n/a
#4
Case#: Subject number 4, female, 11 years (report)
DiseaseAssertion: Pompe disease
FamilyInfo: No known family member with PD
CasePresentingHPOs: HP:0001638 (cardiomyopathy), HP:0002153 (hyperkalemia), HP:0001324 (muscle weakness)
CaseHPOFreeText:
CaseNotHPOs: HP:0003546 (Exercise intolerance), HP:0001252 (Hypotonia), HP:0003326 (Myalgia), HP:0002015 (dysphagia), HP:0002098 (respiratory distress), HP:0002094 (dyspnoea)
CaseNotHPOFreeText: no biopsy, not asymptomatic
CasePreviousTesting: "Enzymatic activity was detected by fluorometric techniques" "The GAA sequence was performed in all patients whose enzyme activity measured in DBS and lymphocytes was decreased."
glucosidase activity: GAA activity was 0.16 mol/Lh in dried blood spots (normal range >0.75).
Variant 1: NM_000152.5(GAA):c.-32-13T>C
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.1831G>A (p.Gly611Ser)
Variant 2 ClinVarID: 935199
Variant 2 CAid: CA401369553
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
Case Report
Case#: Patient (case report), male, 1 month old, ethnicity unknown
DiseaseAssertion: Pompe disease
FamilyInfo: No history of consanguinity in parents. The patient has a 15 months old sibling that is healthy.
Family medical history was notable for tuberous sclerosis in the patient’s father’s first cousin.
CasePresentingHPOs: HP:0200128, HP:0001639, HP:0002240
(Biventricular hypertrophy, Hypertrophic cardiomyopathy, Hepatomegaly,
CaseHPOFreeText: Echogenic mass within the left ventricle.
Short-axis images revealed the possibility of an additional mass within the left ventricle adjacent to the papillary muscles
Right axis deviation
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
Normal results were noted for levels of plasma amino acids, lactate and pyruvate, total and free carnitine, and acylcarnitine compounds. Urine organic acid quantitation was normal.
PR interval was normal
CasePreviousTesting: The serum creatine kinase was elevated (478 U/L; normal 60–305 U/L).
GAA activity in whole blood from a blood spot was 1.8 pmol/punch/hour (control 10–49 pmol/punch/hour)
The GAA gene was sequenced.
Variant 1: NM_000152.5(GAA):c.525del (p.Glu176fs)
ClinVar: 4033
CAID: CA220406
gnomAD: N/A
Variant 2: NM_000152.5(GAA):c.1927G>A (p.Gly643Arg)
ClinVar: 4023
CAID: CA116596
gnomAD: Highest population MAF=0.00003667 (Euroean (non-Finnish))
ParentalGenotype:N/A
PreviouslyPublished:N/A
6
Case#: Subject number 6(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CK testing: 176 U/L (28-300 U/L is normal), AST: 61 U/L (24-72 U/L is normal), ALT: 39 U/L (17-63 U/L is normal), Hex4: 5.9 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal)
glucosidase activity: GAA activity #1 was 1.32 micromole/L/h and GAA activity #2 (NBS) 0.88 in dried blood spots (>2.10 micromole/L/h is normal). 0.7 in confirmatory testing (>6.7 is normal).
Variant 1: NM_000152.5(GAA):c.-32-13T>G
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.-32-13T>G
Variant 2 ClinVarID: 4027
Variant 2 CAid: CA116606
Zygosity: homozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
2
Case#: Subject number 2(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CK testing: 72 U/L (28-300 U/L is normal), AST: 21 U/L (24-72 U/L is normal), ALT: 23 U/L (17-63 U/L is normal), Hex4: 4.2 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal)
glucosidase activity: GAA activity #1 was 1.86 micromole/L/h and GAA activity #2 (NBS) 1.44 in dried blood spots (>2.10 micromole/L/h is normal). 5.3 in confirmatory testing (>6.7 is normal).
Variant 1: NM_000152.5(GAA):c.2238G>C
Variant 1 ClinVarID: 265160
Variant 1 CAid: CA8815665
Variant 2: NM_000152.5(GAA):c.1552-3C>G
Variant 2 ClinVarID: 419722
Variant 2 CAid: CA8815383
Zygosity: compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
17
Case#: Subject number 17(L)
DiseaseAssertion: Late Onset Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: N/A
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CK testing: 275 U/L (60-305 U/L is normal), AST: 150 U/L (22-71 U/L is normal), ALT: 42 U/L (7-50 U/L is normal), Hex4: 5.2 mmol/mol Creatinine (≤20 mmol/mol Creatinine is normal), BNP 44.5 pg/mL (0.0–100.0 pg/mL is normal)
glucosidase activity: GAA activity #1 was 1.04 micromole/L/h and GAA activity #2 (NBS) 0.77 in dried blood spots (>2.10 micromole/L/h is normal). 1.80 in confirmatory testing (>3.88 is normal).
Variant 1: NM_000152.5(GAA):c.-32-13T>G
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.-32-13T>G
Variant 2 ClinVarID: 4027
Variant 2 CAid: CA116606
Zygosity: homozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
Pompe disease is an autosomal recessive inborn error of metabolism caused by mutations in the glucosidase alpha acid (GAA) gene located on the long arm of chromosome 17q25.2-q25.3.
PMID: 33202836
Gene: GAA
Disease: Pompe disease
Inheritance: Autosomal recessive
c.743T > C(p.Leu248Pro)
Case84
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.743T>C (p.Leu248Pro)
CAID: CA401363263 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.743T%3EC
gnomAD: European (Non-Finnish) 1.551e-5, Overall 7.079e-6 http://gnomad.broadinstitute.org/variant/17-78081406-T-C
Variant2: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
CaseAddInfo: Adult Late Onset Pompe Disease
c.525delT(p.Glu176Argfs*45)
Case46
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.525delT (p.Glu176Argfs*45)
ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
Variant2: NM_000152.4:c.1655T>C (p.Leu552Pro)
ClinVar: 279811 https://www.ncbi.nlm.nih.gov/clinvar/variation/279811/
gnomAD: European (Non-Finnish) 7.053e-5, Overall 3.188e-5 http://gnomad.broadinstitute.org/variant/17-78085800-T-C
CaseAddInfo: Infantile Onset Pompe Disease
c.1754+1G > A
Case8
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.1754+1G>A
ClinVar: 286458 https://www.ncbi.nlm.nih.gov/clinvar/variation/286458/
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.722_723delTT (p.Phe241Cysfs*88)
CAID: CA658795235 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.722_723delTT
gnomAD: Not in gnomAD
CaseAddInfo: Infantile Onset Pompe Disease
c.953T > C(p.Met318Thr)
Case55
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.953T>C (p.Met318Thr)
ClinVar: 4021 https://www.ncbi.nlm.nih.gov/clinvar/variation/4021/
gnomAD: African 8.608e-5, Overall 4.485e-5 http://gnomad.broadinstitute.org/variant/17-78081693-T-C
Variant2: NM_000152.4:c.-32-13T>G
ClinVar: 4027 https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
CaseAddInfo: Juvenile Late Onset Pompe Disease
CaseOPOPD-50: Male, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 0.68 umol/hr/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.1634C>T (p.Pro545Leu)
ClinVar: 4032 https://www.ncbi.nlm.nih.gov/clinvar/variation/4032/
gnomAD: European (Finnish) 1.199e-4, Overall 1.774e-5 http://gnomad.broadinstitute.org/variant/17-78084822-C-T
Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele
CaseOPOPD-40: Female, Taiwan, Birth diagnosis
HPOsFreeText: GAA (MS/MS) enzyme activity at 0.99 umol/hr/L
GenotypingMethod: GAA Gene Sequencing and PCR Amplification
Variant1: NM_000152.4:c.872T>C (p.Leu291Pro)
CAID: CA401363854 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.872T%3EC
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
CaseAddInfo: One Pompe Mutation allele and One Pseudodeficency Mutation allele, 2 others have the same genotypes
7
Case#: Patient 7, Gender N/A, Onset 3-4 months. Death around 1-2 years, Southeast Asian
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: P:0001639. HP:0005165, HP:0001270, HP:0002240
(Dyspnea, Shortened PR interval, Motor delay, Hepatomegaly
CaseHPOFreeText: BVH, Severe MR, SDD, CK 550u/l, EF
CaseNotHPOs:
CaseNotHPOFreeText:
CasePreviousTesting: Creatine Kinase enzyme 550u/l, Ejection fraction 30%, GAA enzyme activity in leukocytes was 0.05% of normal control value.
PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions
Variant 1: NM_000152.5(GAA):c.1411_1414del (p.Glu471fs)
ClinVar: 188874
CAID: CA274067
gnomAD: Highest population MAF = 0.0002513 in East Asian
Variant 2: NM_000152.5(GAA):c.1933G>C (p.Asp645His)
ClinVar: 189013
CAID: CA274256
gnomAD: Highest population MAF = 0.00005534 (East Asian)
ParentalGenotype: Father was the carrier of variant 1 NM_000152.5(GAA):c.1411_1414del (p.Glu471fs)
mother was carrier of variant 2 NM_000152.5(GAA):c.1933G>C (p.Asp645His)
PreviouslyPublished: N/A
12
Case#: Patient 12, Gender N/A, Onset at 3-4 months old, Southeast Asian
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001252, HP:0002090, HP:0002878, HP:0005165
(Hypotonia, Pneumonia, Respiratory failure, Shortened PR interval)
CaseHPOFreeText: Failed endotracheal extubation, BVH, mild sub-aortic obstruction, SDD, Ejection fraction 13%, creatine kinase levels 966 u/l
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: GAA enzyme activity in leukocytes was 0.10% of normal control value.
PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions
Variant 1: c.1327-2A>G
ClinVar: N/A
CAID: CA401366177
gnomAD: Highest population MAF = 0.0002297 (African)
Variant 2: c.1437G>C (p.Lys479Asn)
ClinVar: N/A
CAID: CA401366671
gnomAD: N/A
ParentalGenotype: Mother was the carrier of variant 1 c.1327-2A>G
Father was the carrier of variant 2 c.1437G>C (p.Lys479Asn)
PreviouslyPublished:
1
Case#: Patient 1, gender N/A, Age of onset was 7-8 months (died at 3 years of age), Southeast Asian
DiseaseAssertion: Pompe Disease
FamilyInfo:
CasePresentingHPOs: HP:0001252, HP:0001270, HP:0001638, HP:0005165 (Muscular Hypotonia, Motor delay, Cardiomyopathy, Shortened PR interval)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: GAA activity in leukocytes was 0% of the normal control value.
PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions
Variant1: NM_000152.5(GAA):c.876C>G (p.Tyr292Ter)
ClinVar: 637958
CAID: CA401363871
gnomAD: N/A
Variant2: NM_000152.5:c.1003G>A (p.Gly335Arg)
ClinVar: 972790
CAID: CA501005
gnomAD: Highest population MAF = 0.00003266 (South Asian).
ParentalGenotype: Patient inherited variant 1 (NM_000152.5(GAA):c.876C>G (p.Tyr292Ter) from father.
Variant 2 (c.1003G>A (p.Gly335Arg)) was inherited from mother PreviouslyPublished:N/A
2
Case#: Patient 2, Gender N/A, 1-2 months old at onset, Southeast Asian
DiseaseAssertion: Pompe disease
FamilyInfo: Patient has two previously deceased siblings with cardiomyopathy
CasePresentingHPOs: HP:0002789, HP:0002240, HP:0005165, HP:0001639 (Tachypnea, Hepatomegaly, Shortened PR interval, Hypertrophic cardiomyopathy)
CaseHPOFreeText: BVH, EF 30%
CaseNotHPOs: N/A
CaseNotHPOFreeText:N/A
CasePreviousTesting: GAA activity in leukocytes was 0% of the normal control value
PCR of all exons was performed and subsequently subjected to capillary Sanger sequencing in both directions
Variant1: NM_000152.5(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029
CAID: CA116610
gnomAD: Highes population MAF = 0.001729 (East Asian)
Variant2: NM_000152.5(GAA):c.1933G>C (p.Asp645His)
ClinVar:<br /> 189013
CAID: CA274256
gnomAD: Highest population MAF = 0.00005534 (East Asian)
ParentalGenotype: Father was carrier of variant 1 c.1935C>A ( p.Asp645Glu
Mother was carrier of the Variant 2 c.1933G>C (p.Asp645His
PreviouslyPublished:
6
Patient6: Female
CasePresentingHPOs: HP:0002194, HP:0001522
HPOsFreeText: ERT dosage = 20 mg/kg/2 w, CRIM negative
CaseNotHPOs: HP:0004887
NotHPOsFreeText: No reversal of HCM
CaseAddInfo: Symptom onset at 1mo, diagnosis and ERT at 4mo, ERT lasted for 4mo, died at 11mo
CasePMIDs: 22252923, 27629047
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.3:c.1657C>T
CAID: CA401368835, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1657C%3ET
gnomAD: n/a
2
Patient2: female
CasePresentingHPOs: HP:0004887, HP:0002194, HP:0001263, HP:0002463, HP:0002870, HP:0011003, HP:0002289
HPOsFreeText: ERT dosage = 20 mg/kg/2 w, use of BiPAP, could sit independently, HCM reversal, CRIM positive, BiPAP ventilation at night
CaseNotHPOs: HP:0000407
NotHPOsFreeText:
CaseAddInfo: Symptom onset and diagnosis at 1d, ERT at 3w, required BiPAP at 57mo, ERT lasted for 77mo, currently 6.5yo
CasePMIDs: 8401535
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.1927G>A (p.Gly643Arg)
ClinVar: 4023, https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/
gnomAD: 5.884e-05, http://exac.broadinstitute.org/variant/17-78086713-G-A
7
Case#: Subject number 7, male, 62 years (diagnosis), 66 years (baseline visit), 67 years (ERT), 67 years (ventilation)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)
CaseHPOFreeText: mechanical ventilation at last visit
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)
CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
2
Case#: Subject number 2, female, 20 years (diagnosis), 48 years (baseline visit), 39 years (ERT), 34 years (ventilation)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness), HP:0002098 (respiratory distress)
CaseHPOFreeText: mechanical ventilation at Baseline Visit, mechanical ventilation at last visit
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea)
CaseNotHPOFreeText:
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
30
Case#: Subject number 30, male, 12 years (baseline visit)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0003236 (Elevated circulating creatine kinase concentration)
CaseHPOFreeText:
CaseNotHPOs: HP:0002870 (obstructive sleep apnea), HP:0002098 (respiratory distress), HP:0001324 (Muscle Weakness)
CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit, no mechanical ventilation at last visit
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
5
Case#: Subject number 5, female, 20 years (diagnosis), 45 years (baseline visit), 42 years (ERT)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness)
CaseHPOFreeText:
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea), HP:0002098 (respiratory distress)
CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit, no mechanical ventilation at last visit
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
4
Case#: Subject number 4, female, 56 years (diagnosis), 63 years (baseline visit), 59 years (ERT)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001324 (Muscle Weakness)
CaseHPOFreeText:
CaseNotHPOs: HP:0003236 (Elevated circulating creatine kinase concentration), HP:0002870 (obstructive sleep apnea), HP:0002098 (respiratory distress)
CaseNotHPOFreeText: no mechanical ventilation at Baseline Visit, no mechanical ventilation at last visit
CasePreviousTesting: "reduced enzymatic activity on fibroblasts, blood leukocytes or skeletal muscle and/or the presence of two known mutations in the GAA gene"
PreviouslyPublished: N/A
Patient 1
Case#: Patient 1, female, symptoms began at birth, began ERT at 2.4mo
DiseaseAssertion: Pompe Disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0002789, HP:0001639, HP:0010628, HP:0000010 (tachypnea, hypertrophic cardiomyopathy, facial nerve palsy, persistent urinary tract infections)
CaseHPOFreeText: diagnosed IOPD, frequent airway infections, motor function significant decline
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: <1% normal GAA expression in fibroblast; after ERT treatment had 100% enzyme activity in cell lysates; unclear how patient was diagnosed
Variant 1: NM_000152.5:c.2481+102_2646+31del538
Variant 1 ClinVarID: 657307
Variant 1 CAid: CA65879529
Variant 2: NM_000152.5:c.2481+102_2646+31del538
Variant 2 ClinVarID: 657307
Variant 2 CAid: CA658795291
ParentalGenotype: Not provided
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
PMID: 31256280
Gene: GAA
Disease: Pompe Disease
Inheritance: Autosomal Recessive
3.1 Description of the study population
Patient4: IOPD Group, 12 days old
CasePresentingHPOs:
HPOsFreeText: LDH = 432 U/L, CK = 458 U/L, ALT = 37 U/L, AST = 80 U/L, Mann-Whitney Test = 3
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.872T>C
CAID: CA401363854, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401363854
gnomAD: n/a
Variant2: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001240, https://gnomad.broadinstitute.org/variant/17-78086721-C-A
3.1 Description of the study population
Patient2: IOPD Group, 10days old
CasePresentingHPOs:
HPOsFreeText: LDH = 516 U/L, CK = 385 U/L, ALT = 12 U/L, AST = 73 U/L, Mann-Whitney Test = 2
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001240, https://gnomad.broadinstitute.org/variant/17-78086721-C-A
3.1 Description of the study population
Patient8: IOPD Group, 12days old
CasePresentingHPOs:
HPOsFreeText: LDH = 418 U/L, CK = 483 U/L, ALT = 44 U/L, AST = 93 U/L, Mann-Whitney Test = 2
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.1935C>A (p.Asp645Glu)
ClinVar: 4029, https://www.ncbi.nlm.nih.gov/clinvar/variation/4029/
gnomAD: 0.0001240, https://gnomad.broadinstitute.org/variant/17-78086721-C-A
LOPD-9
CaseLOPD-9: 3 weeks diagnosis
HPOsFreeText: GAA activity 4.1 (nmol · h−1 · mg−1), Mean percentage of normal 5.8%
GenotypingMethod: Newborn Screening Panels
Variant1: NM_000152.4:c.266G>A (p.Arg89His)
ClinVar: 283219 https://www.ncbi.nlm.nih.gov/clinvar/variation/283219/
gnomAD: Ashkenazi Jewish 1.168e-3, Overall 1.395e-4 http://gnomad.broadinstitute.org/variant/17-78078651-G-A
Chromosomal code not provided
Variant2: NP_000143.2:p.E176fsX45
ClinVar: N/A
gnomAD: N/A
CaseAddInfo: Late Onset Pompe Disease
PD/Pathogenic-1
CasePD/Pathogenic-1: 5 weeks diagnosis
HPOsFreeText: GAA activity 16.6 (nmol · h−1 · mg−1), Mean percentage of normal 23.2%
GenotypingMethod: Newborn Screening Panels
Variant1: NM_000152.4:c.1726G>A (p.Gly576Ser)
ClinVar: 92467 https://www.ncbi.nlm.nih.gov/clinvar/variation/92467/
gnomAD: East Asian 0.1427, Overall 0.01700 http://gnomad.broadinstitute.org/variant/17-78085871-G-A
Variant2: NM_000152.4:c.2065G>A (p.Glu689Lys)
ClinVar: 4030 https://www.ncbi.nlm.nih.gov/clinvar/variation/4030/
gnomAD: East Asian 0.2355, Overall 0.05524 http://gnomad.broadinstitute.org/variant/17-78087041-G-A
Variant3: NM_000152.4:c.752C>T (p.Ser251Leu)
ClinVar: 325781 https://www.ncbi.nlm.nih.gov/clinvar/variation/325781/
gnomAD: East Asian 2.760e-3, Overall 3.540e-4 http://gnomad.broadinstitute.org/variant/17-78081415-C-T
Variant4: NM_000152.4:c.761C>T (p.Ser254Leu)
ClinVar: 325782 https://www.ncbi.nlm.nih.gov/clinvar/variation/325782/
gnomAD: East Asian 2.759e-3, Overall 1.947e-4 http://gnomad.broadinstitute.org/variant/17-78081424-C-T
CaseAddInfo: Patient has one pseudodeficency allele and one pathogenic allele, Nomenclature claims Variant 1 and 2 are in cis, Nomenclature claims Variant 3 and 4 are in cis
P20
Patient20: Male, 19yo
CasePresentingHPOs:
HPOsFreeText: LOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo: 19yr disease duration, ERT lasted 132mo
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.525delT (p.Glu176Argfs)
ClinVar: 4033, https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: 0.00009959, http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
14
Case#: Subject number 14, male, 63 years (report), 47 years (onset), 58 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0000365 (hearing loss), HP:0000360 (tinnitus)
CaseHPOFreeText: On BiPAP, ambulatory, assistive device (cane)
CaseNotHPOs: HP:0000821, HP:0002650, HP:0002617, HP:0000939, HP:0009830, HP:0100647, HP:0010788, HP:0001638 (hypothyroidism, scoliosis, aneurysm, osteoporosis, peripheral neuropathy, Graves disease, Testicular cancer, cardiomyopathy)
CaseNotHPOFreeText: no infusion reaction, no tracheostomy
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.-32-13T>G (p.Tyr766Ser)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5(GAA):c.1445C>G
Variant 2 ClinVarID: N/A
Variant 2 CAid: CA401366794
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
1
Case#: Subject number 1, male, 22 years (report), 9 years (onset), 11 years (diagnosis)
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0002650, HP:0001638 (Scoliosis, cardiomyopathy)
CaseHPOFreeText: on BiPap, ambulatory
CaseNotHPOs: HP:0002617, HP:0000365, HP:0000360, HP:0000939, HP:0009830, HP:0100647, HP:0010788, HP:0000821 (aneurysm, hearing loss, tinnitus, osteoporosis, peripheral neuropathy, Graves disease, Testicular cancer, hypothyroidism)
CaseNotHPOFreeText: No infusion reaction, no tracheostomy
CasePreviousTesting: “documented deficiency of acid alpha-glucosidase enzyme activity”; on enzyme replacement therapy
Variant 1: NM_000152.5(GAA):c.1655T>C (p.Leu552Pro)
Variant 1 ClinVarID:279811
Variant 1 CAid:CA8815429
Variant 1 gnomAD MAF: 0.00007053; 8/113426 (European non-Finnish)[https://gnomad.broadinstitute.org/variant/17-78085800-T-C?dataset=gnomad_r2_1]
Variant 2: NM_000152.5(GAA):c.2238G>C (p.Trp746Cys)
Variant 2 ClinVarID:265160
Variant 2 CAid:CA9301331
Variant 2 gnomAD MAF: 0.0005673; 73/128684 (European non-Finnish)[https://gnomad.broadinstitute.org/variant/17-78090815-G-C?dataset=gnomad_r2_1]
Zygosity: Compound heterozygous
ParentalGenotype: N/A
PreviouslyPublished: N/A
Detailed characteristics of these patients
Patient2: female, 16yo, juvenile onset
CasePresentingHPOs:
HPOsFreeText: LOPD, BMI = 17.7;20.3;20.3, WGMS = 2;2;2
CaseNotHPOs: HP:0002355
NotHPOsFreeText: did not require respiratory support
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1:NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.307T>G (p.Cys103Gly)
ClinVar: 92483, https://www.ncbi.nlm.nih.gov/clinvar/variation/92483/
gnomAD: n/a
22/F
Patient22: Female
CasePresentingHPOs: HP:0004887, HP:0011471, HP:0001371
HPOsFreeText: CRIM positive, tracheostomy, able to sit independently, heart normalization
CaseNotHPOs: HP:0002546, HP:0000365
NotHPOsFreeText: infusion associated reaction
CaseAddInfo: homozygous variants in trans, symptom onset and diagnosis at 4yo, ERT at 5yo
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.1927G>A (p.Gly643Arg)
ClinVar: 4023, https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/
gnomAD: 0.00002479, http://gnomad.broadinstitute.org/variant/17-78086713-G-A
21/F
Patient 21: Female
CasePresentingHPOs: HP:0004887, HP:0011471, HP:0002546, HP:0000365, HP:0001371, HP:0100845
HPOsFreeText: CRIM positive, infusion associated reaction, tracheostomy, able to sit independently, heart normalization
CaseNotHPOs:
CaseAddInfo: variants in trans, symptom onset at birth, diagnosis at 19 days, ERT at 1yo
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.3:c.930_932del
CAID: CA913184760, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184760
Variant2: NM_000152.4(GAA):c.1927G>A (p.Gly643Arg)
ClinVar: 4023, https://www.ncbi.nlm.nih.gov/clinvar/variation/4023/
gnomAD: 0.00002479, http://gnomad.broadinstitute.org/variant/17-78086713-G-A
2
Case# Patient 2, male
CasePresentingHPOs: HP:0003236, HP:0003325
CaseAddInfo: 66 at onset, 72 at diagnosis
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: NM_000152.4(GAA):c.525delT (p.Glu176Argfs)
ClinVar: 4033
gnomAD: 7.041e-05, http://exac.broadinstitute.org/variant/17-78078909-CT-C
Clinical and laboratory features of the 17 newly diagnosed patients with LOPD
GroupPresentingHPOs: HP:0003325, HP:0003457, HP:0012548, HP:0004887, HP:0010535, HP:0001712, HP:0031296
HPOsFreeText: hyperCKaemia+LGMW, BMI, mean (SD) 25.2±5.8, Serum CK, mean (SD) 600±302, vacuolar myopathy, Muscle GAA %, mean (SD) 9.4±3.8, myogenic EMG, abnormal MRI, %Predicted FVC, mean (SD) 73±11, 6MWT, mean (SD) 452±9, vacuolisation of myofibers with variable glycogen storage, AP staining low in 6 individuals, medium in five, and high in 2 individuals. Low residual GAA activity in muscles,
GroupNotHPOs:
NotHPOsFreeText:
NumberMales: 8
NumberFemales: 9
CountryOrigin: n/a
AgeRange: mean (SD) 40±14.36
TotalNumber: 14
GroupAddInfo: mean age at disease onset was 40±14.3 years, median age at disease diagnosis was 47±14 years. 14 of the individuals underwent enzyme replacement therapy. Blood CK levels increased in all but one individual.
GroupGenotypingMethod: GAA gene sequencing
Variant 1: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant 2: p.P522A, NM_000152.4(GAA):c.1564C>G (p.Pro522Ala)
ClinVar: 371277, https://www.ncbi.nlm.nih.gov/clinvar/variation/371277/
gnomAD: n/a
10
Case#: Patient 10, male
CasePresentingHPOs: HP:0003236
CaseAddInfo: 34yo at onset, 42yo at diagnosis
Variant: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
4
Case# Patient 4, female
CasePresentingHPOs: HP:0003236, HP:0003325
CaseAddInfo: 31yo at onset, 40yo at diagnosis
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
ClinVar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: NM_000152.4(GAA):c.1564C>G (p.Pro522Ala)
ClinVar: 371277, https://www.ncbi.nlm.nih.gov/clinvar/variation/371277/
gnomAD: n/a
2
Patient2: Female, 10 years report, 4 months onset
CasePresentingHPOs: HP:0001640, HP:0002098, HP:0002240 (Cardiomegaly, Respiratory distress, Hepatomegaly)
HPOsFreeText: GAA activity 4.6% from leukocyte, Respiratory Assistance needed
CaseNotHPOs: HP:0001324 (Muscle weakness)
NotHPOsFreeText: No wheelchair needed
CaseAddInfo: IOPD
36
Patient36: Male, 3 year onset
CasePresentingHPOs: HP:0001324, HP:0002098, HP:0003236 (Muscle weakness, Respiratory distress, Increased serum CK)
HPOsFreeText: GAA activity 5.7% from leukocyte, Wheelchair needed, Respiratory Assistance needed
CaseNotHPOs: HP:0001640, HP:0002240 (Cardiomegaly, Hepatomegaly)
NotHPOsFreeText: N/A
CaseAddInfo: LOPD550825
17
Case#: P 17, Female, 5.5 mo nths old when started ERT (62.8 months old when last reported), German
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: P:0001639 , HP:0001252 , HP:0003701, HP:0006532
(Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Recurrent Pneumonia)
CaseHPOFreeText: Recurrent pneumonia was a complication during ERT
Best and last motor status was walking
CaseNotHPOs: N/A
CaseNotHPOFreeText: Did not required tube feeding nor ventilation
CasePreviousTesting: CRIM status was unknown
Antibody titer 1:800
Variant: NM_000152.5(GAA):c.1978C>T (p.Arg660Cys)
ClinVar: 558604
CAID: CA8815561
gnomAD: MAF=0.00005554 in East Asian
ParentalGenotype: Both the paternal and maternal allele carried the NM_000152.5(GAA):c.1978C>T (p.Arg660Cys) Variant
PreviouslyPublished: N/A
11
Case#: P 11, Male, 2.6 months old when started ERT (Died at 14.1 months old), German
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0011951
(Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Aspiration pneumonia )
CaseHPOFreeText: AR IV
Patient required ventilation and tube feeding
No motor activity reported
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: CRIM status is negative
Antibody titer is 1:51.200
Variant: NM_000152.5(GAA):c.1548G>A (p.Trp516Ter)
ClinVar: 189025
CAID: CA274281
gnomAD: MAF=0.00001552 in European non-Finnish
ParentalGenotype: Both the paternal and maternal allele carry the variant c.1548G>A (p.Trp516Ter)
PreviouslyPublished: N/A
3
Case#: P 3, Male, 4.9 months when started ERT (122.1 months old at publication date), Ethnicity unknown
DiseaseAssertion: Pompe disease
FamilyInfo: Table 1 includes parental genotype
CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0002028
(Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Chronic diarrhea )
CaseHPOFreeText: Chronic diarrhea was a complication during ERT
Patient best and last/current status was being able to sit
CaseNotHPOs: N/A
CaseNotHPOFreeText: Patient did not required tube feeding
Patient did not required ventilation
CasePreviousTesting: CRIM status is positive in patient
Antibody titer is 1:200
Variant 1: c.IVS17 + 102_IVS18 + 3
ClinVar: N/A
CAID: 657307
gnomAD: N/A
Variant 2: c.1465G>T (p.Asp489Tyr)
ClinVar: N/A
CAID: CA401366871
gnomAD: N/A
ParentalGenotype: The maternal allele of the patient carried the c.IVS17 + 102_IVS18 + 31 Variant
The paternal allele of the patient carried the c.1465G>T (p.Glu489Ter) Variant
PreviouslyPublished: N/A
7
Case#: P 7, Female, 2.3 months old when started ERT (90.6 months old at publication date), ethnicity unknown
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001639 , HP:0001252 , HP:0003701, HP:0031846, HP:0030242
(Hypertrophic cardiomyopathy, Muscular hypotonia, Proximal muscle weakness, Femur fracture, Portal vein thrombosis)
CaseHPOFreeText: Femur fracture and Port thrombosis were complications during ERT
Best motor status was walking, last motor status was sitting
Patient required ventilation
CaseNotHPOs: N/A
CaseNotHPOFreeText: Did not required tube feeding
CasePreviousTesting: CRIM status is positive
Antibody titer is 1:800
Variant: NM_000152.5(GAA):c.1933G>A (p.Asp645Asn)
ClinVar: 188728
CAID: CA273892
gnomAD: Highest population MAF= 0.00006599 in Africans
ParentalGenotype: Both the paternal and maternal allele carried the variant c.1933G>A (p.Asp645Asn)
PreviouslyPublished: N/A
10
Family 10 - Patient 10
FamilyPresentingHPOs: HP:0007340, HP:0003701, HP:0003327, HP:0040081, HP:0002111
HPOsFreeText: muscle pathology with vacuolar myopathy
FamilyNotHPOs: HP:0010628, HP:0002015, HP:0003691, HP:0003306, HP:0002650
Ethnicity: Iranian
ProbandLabel:
FamilyAddInfo: onset at 38yo, diagnosis at 50yo, MRC sum score = 73, patient required use of NIV
FamilyPreviousTesting: Respiratory Evaluation: FVC = 65%, CK = 551 U/L, muscle pathology examined, DBS enzyme activity (with inhibition) = 0.12 μmol/L/h
FamilyGenotypingMethod: GAA analyzed with Sanger Sequencing for entire coding region and conserved exon-intron splice junctions, PCR performed for deletion screening
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: NM_000152.3:c.2596delG
CAID: CA891834514, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA891834514
gnomAD: n/a
4a
Family 4 - Patients 4a and 4b
FamilyPresentingHPOs: HP:0007340, HP:0003701, HP:0000467, HP:0003327, HP:0010628, HP:0002015, HP:0003306, HP:0002111, HP:0011807, HP:0003554, HP:0002111, HP:0100298, HP:0040081
HPOsFreeText: myopathic muscle unit action potentials, 4b muscular pathology with mild atrophy of type 1 and 2 fibers with many moth‐eaten fibers, no vacuoles, no glycogen excess
FamilyNotHPOs: HP:0003691, HP:0002650
NotHPOsFreeText:
Ethnicity: Iranian
ProbandLabel: 4a, female, 7yo at onset, 30yo at diagnosis
FamilyAddInfo: 4b (male) dx at 23yo, 4a MRC sum score = 84, 4b MRC sum score = 86, both patients required use of NIV
FamilyPreviousTesting: Respiratory Evaluation: 4a FVC = 29%, 4b FVC = 66%, 4a CK = 760 U/L, 4b CK = 3,257 U/L, muscle pathology (examined only in 4b), DBS enzyme activity (with inhibition) for 4a = 0.1 μmol/L/h, for 4b = 0.13 μmol/L/h, NCS, EMG
FamilyGenotypingMethod: GAA analyzed with Sanger Sequencing for entire coding region and conserved exon-intron splice junctions, PCR performed for deletion screening
VariantAllele1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
VariantAllele2: NM_000152.3:c.1650delG
Clinvar: n/a
CAID: CA627699787, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA627699787
gnomAD: n/a
1
Case#: Patient 1, Gender N/A, age N/A, ethnicity unknown
DiseaseAssertion: Pompe disease
FamilyInfo: N/A
CasePresentingHPOs: HP:0001638, HP:0003756
(Cardiomyopathy, Skeletal myopathy)
CaseHPOFreeText: N/A
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: Sequence analysis of the GAA gene was performed in a CLIA and CAP certified laboratory.
Cross Reactive Immune reaction was indeterminate in peripheral blood mononuclear cells (PBMCs)
Cross Reactive Immune reaction was negative in Dried blood spots.
Variant 1: c.437delT (p.Met146ArgfsX7)
ClinVar: N/A
CAID: N/A
gnomAD: N/A
Variant 2: NM_000152.5(GAA):c.2237G>A (p.Trp746Ter)
ClinVar: 280063
CAID: CA8815664
gnomAD: Two variants with same consequence (protein) were identified.
Highest population MAF = 0.00004011 (African)
Highest population MAF = 0.000008834 (European non-Finnish)
ParentalGenotype: N/A
Previously published: N/A
8
Case8: Male, 53 years report, Italy
CasePresentingHPOs: HP:0003551, HP:0002098 (Difficulty climbing stairs, Respiratory distress)
HPOsFreeText: Height is 1.85 m, Weight is 106 kg, BMI is 31.0 kg/cm2, 7 years on ERT, Forced Vital Capacity at 55%, Nocturnal non-invasive ventilation
CaseAddInfo: Late Onset Pompe Disease
2
Case2: Male, 47 years report, Italy
HPOsFreeText: Height is 1.90 m, Weight is 112 kg, BMI is 31.0 kg/cm2, 4 years on ERT, Forced Vital Capacity at 112%
CaseNotHPOs: HP:0002098 (Respiratory distress)
NotHPOsFreeText: Nocturnal non-invasive ventilation
CaseAddInfo: Late Onset Pompe Disease
c.380G>A
Variant: NM_000152.4:c.380G>A (p.Cys127Tyr)
CAID: CA401360975 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.380G%3EA
gnomAD: Not in gnomAD
VariantAddInfo: This variant was declared as novel and found in a patient, but no further information was given.
c.878G>T
Variant: NM_000152.4:c.878G>T (p.Gly293Val)
CAID: CA401363883 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.878G%3ET
gnomAD: Not in gnomAD
VariantAddInfo: This variant was declared as novel and found in a patient, but no further information was given.
c.1447G>T
Variant: NM_000152.4:c.1447G>T (p.Gly483Trp)
CAID: CA401366801 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.3%3Ac.1447G%3ET
gnomAD: Not in gnomAD
VariantAddInfo: This variant was declared as novel and found in a patient, but no further information was given.
For GAA (Pompe disease) screening,
CaseP5-GAA: female, ethnicity = South Asian, country origin = Nepal
CasePresentingHPOs:
HPOsFreeText: enzyme activity = 2.27
CaseNotHPOs: HP:0010899, HP:0010916, HP:0003236
CaseAddInfo: known pseudodeficiency allele (c.1726G>A)
CasePreviousTesting: initial and confirmatory DBS, biochemical tests
CaseGenotypingMethod: mutation analyses
Variant: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: n/a
3
Case3: Female, 0.8 yr onset, 1.1 yr diagnosis, 8.9 yr report
CasePresentingHPOs: HP:0005165 (Shortened PR interval)
HPOsFreeText: FVC z-score sitting 0.21 (102% pred), FVC z-score supine 0.1 (101% pred), 358 CK U/l, 13.3 GAA activity (nmol/h/mg)^h from cultured fibroblasts, ECG showed delta wave suggestive of Wolff-Parkinson-White syndrome
NotHPOsFreeText: No wheelchair used, no respiratory support
Case22: Female, 46 years report
HPOsFreeText: 3 years of ERT completed, 6 Minute Walking Test at 73 meters, Forced Vital Capacity at 68%
GenotypingMethod: GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.1819_1836del (p.Gly607_His612del )
CAID: CA658795266 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1819_1836del
gnomAD: Not in gnomAD
CaseAddInfo: Late Onset Pompe Disease
Case11: Male, 57 years report
HPOsFreeText: 9 years of ERT completed, 6 Minute Walking Test at 210 meters, Forced Vital Capacity at 31%
GenotypingMethod: GAA Gene Sequencing
Variant1: NM_000152.4:c.-32-13T>G
ClinVar: 4027 http://www.ncbi.nlm.nih.gov/clinvar/variation/4027
gnomAD: Ashkenazi Jewish 5.541e-3, Overall 3.401e-3 http://gnomad.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4:c.525delT (p.Glu176Argfs*42)
ClinVar: 4033 https://www.ncbi.nlm.nih.gov/clinvar/variation/4033/
gnomAD: European (Non-Finnish) 1.880e-4, Overall 9.959e-5 http://gnomad.broadinstitute.org/variant/17-78078909-CT-C
CaseAddInfo: Late Onset Pompe Disease
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study
PMID: 30832705 Gene: GAA
PD25
Patient25: Male, Southern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: c.971dupC (p.Ser325GlufsX5) no ClinVar or CAID
Variant2: NM_000152.4(GAA):c.1802C>T (p.Ser601Leu)
ClinVar: 194154, https://www.ncbi.nlm.nih.gov/clinvar/variation/194154/
gnomAD: n/a
PD13
Patient13: Female, Northern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1802C>T (p.Ser601Leu)
ClinVar: 194154, https://www.ncbi.nlm.nih.gov/clinvar/variation/194154/
gnomAD: n/a
Variant2: NM_000152.3:c.2411G>A
CAID: CA401325125, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401325125
gnomAD: n/a
2
Case2: Male, 18 years diagnosis, 1 year onset
CasePresentingHPOs: HP:0009073, HP:0003198, HP:0003236, HP:0003327, HP:0008994 (Progressive proximal muscle weakness, Myopathy, Increased serum CK, Axial muscle weakness, Proximal muscle weakness in lower limbs)
HPOsFreeText: Electromyography showed myogenic damage, Vacuolar myopathy, Serum CK is 1168.3 U/L
P4
Case#: Subject number 4, male, 5 months (onset), 34 months (first admission)
DiseaseAssertion: Pompe disease
FamilyInfo: "no family history of neuromuscular disorders"
CasePresentingHPOs: HP:0001712 (left ventricular hypertrophy), HP:0002194 (delayed gross motor development), HP:0004887 (respiratory failure requiring assisted ventilation), HP:0002090 (pneumonia), HP:0002205 (recurrent respiratory infections), HP:0003819 (death in childhood)
CaseHPOFreeText: ambulatory (transport ventilator), infantile-onset
CaseNotHPOs:
CaseNotHPOFreeText: no tracheostomy, no dysphagia at baseline, not on BiPAP
CasePreviousTesting: “GAA activity in peripheral blood leukocytes lower than normal”; on enzyme replacement therapy
PD21
Patient21: Female, Northern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1802C>T (p.Ser601Leu)
ClinVar: 194154, https://www.ncbi.nlm.nih.gov/clinvar/variation/194154/
gnomAD: n/a
Variant2: NM_000152.3:c.1844G>T
CAID: CA401369601, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401369601
gnomAD: n/a
PD06
Patient6: Male, northern China
CasePresentingHPOs:
HPOsFreeText: IOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.1115A>T (p.His372Leu)
ClinVar: 370483, https://www.ncbi.nlm.nih.gov/clinvar/variation/370483/
gnomAD: n/a
Variant2: NM_000152.3:c.2563G>C
CAID: CA401326195, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA401326195
gnomAD: 0.00003188, http://gnomad.broadinstitute.org/variant/17-78092073-G-C
The nature of respiratory muscle weakness in patients with late-onset Pompe disease
PMID: 31327549
Gene: GAA
Disease: Pompe Disease
Inheritance: Autosomal Recessive
35-year-old female
Case1: Female, 33 years onset, 35 years report
CasePresentingHPOs: HP:0030148, HP:0002094, HP:0001644, HP:0001712, HP:0006673, HP:0025168, HP:0030718, HP:0031295, HP:0001667, HP:0012667, HP:0006673, HP:0031185, HP:0002150, HP:0003165, HP:0008200, HP:0008208, HP:0002375, HP:0030232, HP:0004356, HP:0001685, HP:0040014, HP:0100295, HP:0001297 (Cardiac murmur, Dyspnea, Dilated cardiomyopathy, Left ventricular hypertrophy, Reduced systolic function, Left ventricular diastolic dysfunction, Right atrial enlargement, Left atrial enlargement, Right ventricular hypertrophy, Regional left ventricular wall motion abnormality, Reduced systolic function, Increased NT-proBNP level, Hypercalciuria, Elevated serum PTH, Primary hyperparathyroidism, Parathyroid hyperplasia, Hypokinesia, Increased sarcoplasmic glycogen, Abnormality of lysosomal metabolism, Myocardial fibrosis, Increased mitochondrial number, Muscle fiber atrophy, Stroke)
HPOsFreeText: At 33 years patient had left ventricular ejection fraction (LVEF) of 35% (normal 54–76%), while 7 months later she had LV volume of 81 ml (systolic) and 127 ml (diastolic), LV mass index (2D) of 141 g/m2; LV septum thickness of 12 mm (normal 7–10 mm); LV posterior wall thickness of 9 mm (normal 7–11 mm); end-diastolic LV diameter of 55 mm (normal 39–53 mm), and LVEF of 34% and Liver longitudinal peak systolic strain of ~8% (normal < −18%); A subsequent MRI confirmed an LVEF of 32% (normal 54–85%), LV volume/Body Surface Area (BSA) of 91 ml/m2 (systolic, normal 12–36 ml/m2) and 134 ml/m2 (diastolic, normal 49–90 ml/m2), and LV mass/BSA of 66 g/m2 (diastolic, normal 59–103 g/m2); Extensive biventricular delayed myocardial enhancement predominantly in the epicardial and transmural muscles was noted; Pro-BNP level was elevated to 3,894 pg/ml; Histologic analysis of formalin-fixed tissue revealed prominent myocyte vacuolization that were dilled with glycogen; GAA activity was measured twice in dried blood spots - once with carrier levels and once with affected levels, however the GAA activity in skin fibroblasts (16.7% normal: 260±80 nmol/h/mg protein) and in heart biopsy tissue (0.07; normal: 0.89±0.42 μmol/min/g tissue) was clearly in the affected range and partially reduced in the muscle biopsy tissues (5.86; 38% of normal: 22.91±8.4 nmol/h/mg protein); Both muscle and heart tissue glycogen content and structure tested in the low or normal ranges (muscle glycogen content 0.11 umol glucose/mg tissue; normal 0.39–1.5; muscle glycogen structure measured as glucose-1-phosphate/glucose ratio 72.22%; normal > 5%; heart glycogen content 0.14 umol glucose/mg tissue; normal > 0.047; and heart glycogen structure 23.91%; normal > 5%); Urine glucose tetrasaccharides biomarker level was normal at 1.0 mmol/mol cr (<4); The patient was also noted to have elevation of calcium (11.6 mg/dl, reference 8.9–10.1 mg/dl) and PTH (541 pg/ml, reference 15–65 pg/ml); Skeletal muscle biopsy showed denervation atrophy; Several months after LVEF declined to 20–25% (normal 54–76%) with CK-MB being 36 U/l (normal 7.0–25.0 U/l); Patient had slightly weak back extensors and her 6-min walk test showed 76.9% predicted for her age and gender
CaseNotHPOs: HP:0040081, HP:0002792, HP:0001324, HP:0002167, HP:0000157 (Abnormal levels of creatine kinase in blood, Reduced vital capacity, Muscle weakness, Speech impairment, Lingual abnormality)
NotHPOsFreeText: Branching enzyme activity in the heart and muscle tissue was normal; Phosphofructokinase and myophosphorylase enzymatic activities were intact
CaseAddInfo: No family history of cardiomyopathy or sudden death
7
Case#: Patient 7, female, diagnosed 2013 (not given age of diagnosis), age 25 during study period
DiseaseAssertion: Pompe Disease
FamilyInfo: None given
CasePresentingHPOs: None given
CaseHPOFreeText: Requires wheelchair for long distance movement
CaseNotHPOs: None given
CaseNotHPOFreeText: None given
CasePreviousTesting: None given
Variant 1: NM_000152.5:c.-32-13T>G (unclear variant nomenclature)
Variant 1 ClinVarID: 4027
Variant 1 CAid: CA116606
Variant 2: NM_000152.5:c.525del (unclear variant nomenclature)
Variant 2 ClinVarID: N/A
Variant 2 CAid: CA220406
ParentalGenotype: Not provided
to assess the potential effects of AMO treatment on GAA normal spliced mRNA expression and activity, as well as on the pathological phenotype in muscle cells, we obtained myoblasts from a LO-GSDII patient who presented the c.-32-13T > G mutation in compound heterozygosity with the c.2646_2646+1delTG mutation in exon 18
Patient2: myoblasts from this patient were used to measure the effects of AMO tratment on GAA normal spliced mRNA expression/activity and the pathological phenotype in muscle cells. Under basal conditions, these myotubes retained 20% of enzymatic activity compared to WT. AMO treatment partially restored the correctly splice variant of GAA mRNA (confirmed via real-time PCR).
CasePresentingHPOs:
HPOsFreeText: LOPD
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: n/a
CaseGenotypingMethod: comparative DNA vs. mRNA sequencing
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.2646_2647del
CAID: CA913184745, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA913184745
gnomAD: n/a
13
Patient13: Male, 46yo at diagnosis, 47yo at ERT
CasePresentingHPOs:
HPOsFreeText: anti rh-GAA antibodies titre = 1:25,699, enzyme (μmol/g/h) = 0.52 (3-20)
CaseNotHPOs:
NotHPOsFreeText: NIV and mobility aid not required
CaseAddInfo: 6yr disease duration, variants in trans
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.3:c.482_483del
CAID: CA8814879, http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA8814879
gnomAD: 1.729e-05, http://exac.broadinstitute.org/variant/17-78078864-TCC-T
16
Patient16: Female, 37yo at diagnosis and ERT
CasePresentingHPOs:
HPOsFreeText: anti rh-GAA antibodies titre = neg, enzyme (μmol/g/h) = 0.18 (3-20), mobility aid required before and after ERT
CaseNotHPOs:
NotHPOsFreeText: NIV not required
CaseAddInfo: 21yr disease duration
CasePMIDs:
CasePreviousTesting: same as group
CaseGenotypingMethod: same as group
Variant: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
(II-3
Subject II-3: male
CasePresentingHPOs:
HPOsFreeText: altered DBS, reduced GAA activity
CaseNotHPOs:
NotHPOsFreeText:
CaseAddInfo:
CasePMIDs:
CasePreviousTesting: DBS
CaseGenotypingMethod: GAA genotyping
Variant1: NM_000152.4(GAA):c.-32-13T>G
Clinvar: 4027, https://www.ncbi.nlm.nih.gov/clinvar/variation/4027/
gnomAD: 0.003582, http://exac.broadinstitute.org/variant/17-78078341-T-G
Variant2: NM_000152.4(GAA):c.2560C>T (p.Arg854Ter)
ClinVar: 4034, https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/
gnomAD: 0.0002090, http://gnomad.broadinstitute.org/variant/17-78092070-C-T
Ten patients received concomitant immunomodulation (detailed in Supplementary Table S4); six were genotype-predicted as CRIM-negative, three were CRIM-positive, and one lacked genotype data.
Patient 9 - homozygous
Variant: NM_000152.4(GAA):c.2560C>T (p.Arg854Ter)
ClinVar: 4034, https://www.ncbi.nlm.nih.gov/clinvar/variation/4034/
gnomAD: 0.0002090, http://gnomad.broadinstitute.org/variant/17-78092070-C-T